Safety alerts

Drug lookup, recalls and shortages

Look up any drug for its FDA label, shortage status and recalls. Below: the recalls that matter most right now, every recall of the last 90 days and every drug in shortage.

New recall alerts

From the last 30 days, often days or weeks before they reach the FDA’s weekly records: the FDA’s own device recall alerts and safety advisories, companies’ recall announcements (drugs, devices, supplements, and foods contaminated with germs or lead), and the USDA’s meat and poultry alerts

Recalls to know about

From the FDA’s recall records, with its newest postings as of Nov. 11 at 1:38 PM CT. Ranked by seriousness, how widely the drug is used, reach and recency

  • Aug. 26, 2026

    Drug recall, ongoing

    Cyanocobalamin and Trace Elements Injection 4 and 7 more (12 products)

    American Regent, sold nationwide

    Cyanocobalamin 10,000 mcg/10 mL, Multrys (Trace Elements Injection 4), acetylcysteine 20%, and papaverine 60 mg/2 mL vials were recalled because particles were found. Lots 25082, 25163 and other lots, expiring 9/30/2026 to 8/31/2027, were sold nationwide in the U.S.

    FDA reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

    Class I: could cause serious harm or death

    About 1.8 million people in the US are prescribed cyanocobalamin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Valuhealth Extra Strength Pain Relief Acetaminophen

    Prodose, sold nationwide

    ValuHealth acetaminophen 500 mg, 40-caplet bottles, was recalled because the bottle label says Pain Relief PM instead of acetaminophen. Lot P260252, exp. 4/30/2029, was distributed nationwide in the USA.

    FDA reason: Incorrect label placed on product: Outer carton label correctly identifies drug product in bottle as ValuHealth Extra Strength Pain Relief Acetaminophen 500 mg,but inner label on bottle says ValuHealth Extra Strength...

    Class III: unlikely to cause harm

    In the news: 11 news outlets mentioned acetaminophen in recall stories in the last two weeks.

    About 6.5 million people in the US are prescribed acetaminophen each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide

    Macleods Pharma USA, sold nationwide

    Olmesartan medoxomil/amlodipine/hydrochlorothiazide tablets, 40 mg/10 mg/12.5mg, in 30-count and 90-count bottles, were recalled because they may not dissolve as required, so the body may absorb less drug than intended. Lots 12251163A and 12251163B, both expiring 05-31-2027, were sold nationwide in the USA.

    FDA reason: Failed Dissolution Specifications.

    Class II: could cause temporary or reversible harm

    In the news: 19 news outlets mentioned olmesartan in recall stories in the last two weeks.

    About 18.4 million people in the US are prescribed amlodipine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Amlodipine and Olmesartan Medoxomil

    Ascend Laboratories, sold nationwide

    Ascend recalled amlodipine/olmesartan 10mg/40mg, 30-tablet bottles because they did not dissolve as required, so the body may absorb less drug than intended. Lot # 25120696, expiring December 31, 2026, was sold nationwide in the United States.

    FDA reason: Out of specification due to dissolution.

    Class II: could cause temporary or reversible harm

    About 18.4 million people in the US are prescribed amlodipine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Levothyroxine Sodium (12 products)

    Accord Healthcare, sold nationwide

    Accord recalled 25, 50, 125 and 200 mcg levothyroxine tablets in 1000-count bottles, and 200 mcg in 90-count bottles, after tests found less active ingredient than labeled. Lots D2402430, D2402431 and other lots, expiring 08/31/2026 to 01/31/2027, went nationwide.

    FDA reason: Subpotent Drug

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Semaglutide (11 products)

    Apollo Care, sold nationwide

    Apollo Care recalled semaglutide 7.5 mg, 12.5 mg, 2.25 mg and 2.5 mg sterile multi-dose vials (1.5, 5 or 2.5 mL) after finding foreign particles. Lots AC-017273, AC-017108 and other lots, expiring 8/30/2026 to 5/5/2027, were sold nationwide.

    FDA reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

    Class II: could cause temporary or reversible harm

    About 8.3 million people in the US are prescribed semaglutide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Levothyroxine Sodium (2 products)

    Pfizer, sold nationwide

    Levoxyl 175 mcg tablets in 100- and 1000-count bottles were recalled after testing found less active ingredient than the label states. Lots 24W06 and 24W07, expiring 11/30/2026, were sold nationwide and in Puerto Rico.

    FDA reason: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Brush Buddies and Evo and 3 more (17 products)

    Pritam International Private Limited, sold nationwide

    Brush Buddies and evo toothpastes, sodium fluoride 0.24% or 0.243%, 3.5- or 4.0-oz tubes, were recalled because they were not made under federal quality rules. Lots LWP240022080309, LWP250035710304C and other lots, exp. 11/30/2026 to 06/04/2028, were sold nationwide.

    FDA reason: CGMP Deviations.

    Class II: could cause temporary or reversible harm

    About 600,000 people in the US are prescribed sodium fluoride each year.

    The FDA record, with lot numbers (opens in a new tab)

All recalls, last 90 days

447 recalls, newest first

  • Nov. 10, 2026

    Drug recall, ongoing

    Metoprolol Tartrate Tablets

    Advagen Pharma Limited

    Why: Presence of Foreign Tablets/Capsules

    Class II: could cause temporary or reversible harm

    About 14.6 million people in the US are prescribed metoprolol each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 10, 2026

    Device recall, ongoing

    Physitemp Ret-1 Rectal Probe Model/Catalog Number: Ret-1 and Physitemp Eso-1 for Esophageal and General Purpose Use Ref: Eso-1 . and 8 more (10 items)

    Physitemp Instruments

    Why: Temperature monitors and associated probes have not been reviewed for safety and effectiveness for intended use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 10, 2026

    Device recall, ongoing

    Medline Convenience Kits Containing Bd Urinary Catheter Trays That Include Clini (10 items)

    Medline Industries

    Why: Convenience kits contain additional product codes and lots of recalled CliniClean Pericare Wipes identified by manufacturer. Wipes may be contaminated with a lubricant used in the manufacturing process. Use of affected...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 10, 2026

    Device recall, ongoing

    Eleganz Fusion Screw System (2 items)

    Dev4

    Why: Driver bit included in fusion Screw System may fracture or break during use resulting in intraoperative delay.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 9, 2026

    Food recall, ongoing

    Country Creek Acres Alfalfa Sprout Seeds Packed in A Clear and Silver Poly Bag

    Country Creek

    Why: Products contain seed recalled from the supplier and may be contaminated with E. coli and/or Salmonella

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 9, 2026

    Food recall, ongoing

    Cold Smoked Sprats

    D & M Smoked Fish

    Why: May be contaminated with Clostridium botulinum

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 9, 2026

    Food recall, ongoing

    Alfalfa Sprouts Hydroponically Grown.

    Francisco Family Foods

    Why: Potential E. coli and Salmonella contamination

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 9, 2026

    Device recall, ongoing

    Ams

    Boston Scientific

    Why: Potential for the Rear Tip Extender (RTE) size contained within the package to differ from the size identified on the product labeling. Certain packages labeled as containing a 0.5 cm RTE may contain a 1.5 cm RTE.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 9, 2026

    Device recall, ongoing

    Straumann Blc Implants and Straumann Healing Abutments (2 items)

    Straumann USA

    Why: Potential exposure to contamination, possibly compromising the sterility and cleanliness.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 9, 2026

    Drug recall, ongoing

    Umary Acido Hialuronico

    Ibeautistore.Com

    Why: Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 7, 2026

    Device recall, ongoing

    Cardinal Health Presource Pbds Kits (2 items)

    Cardinal Health 200

    Why: Notification of performance disclosures of kit component.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Drug recall, ongoing

    Lisdexamfetamine Dimesylate Capsules

    Sun Pharmaceutical Industries

    Why: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    About 1.6 million people in the US are prescribed lisdexamfetamine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Vesco Q Enteral Feeding Pump and Vesco Q and 1 more (7 items)

    Vesco Medical

    Why: The feeding pump may deliver enteral fluids outside its labeled accuracy specification of +/-5%. This inaccuracy can result in over-delivery or under-delivery of enteral fluids relative to the prescribed dose, if proper...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Drug recall, ongoing

    Orl Organic Oral Care Bubblegum Kids Natural Toothpaste and Orl Organic Oral Care Cinnamint Toothpaste and 4 more (6 products)

    Orl Labs

    Why: Cross-contamination: The firm was notified by the FDA of sampling results which found the presence of progesterone, estradiol, or dehydroepiandrosterone (DHEA)

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Food recall, ongoing

    Raw Milk Cheddar Cheese Packed in Vacuum Sealed Clear Plastic with A White

    Family Farmstead Dairy

    Why: Potential contamination with E. coli (pathogenic non-O157 STEC).

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Gore¿ Viabahn¿ Endoprosthesis with Heparin Bioactive Surface

    W L Gore & Associates

    Why: Endovascular prosthesis were manufactured on equipment that was not operating with valid parameters and may cause the distal tip to separate.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Zynex Medical M-Wave

    Altivera Medical

    Why: Muscle stimulator may deliver constant electrical impulses to all four electrodes simultaneously, instead of alternating between the electrodes as designed, which may cause muscle fatigue.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Philips Allura Xper Systems with Software Releases R8.1.X and R8.2.X Systems and

    Philips Medical Systems Nederland B.V.

    Why: Software issue that may cause the FlexVision software application to become unresponsive during clinical use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Acuson Orgin Ultrasound Imaging System Ref: and Acuson Orgin Ice Ultrasound Imaging System Ref: and 2 more (4 items)

    Siemens Medical Solutions USA

    Why: A software issue identified in the ultrasound system may result in the unintended activation of the Color Doppler setting, which has not received FDA clearance. This unintended activation could cause the system to crash...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Tcd Electrodes

    Boston Scientific Neuromodulation

    Why: Radiofrequency probes may have small cut marks on the Tyvek side of the sterile pouch, and if the sterile barrier is compromised and devices are used, this could cause microbial or other foreign material contamination...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Carelink Smartsync Device Manager App and Programmer and 1 more (3 items)

    Medtronic

    Why: Bluetooth disconnections may occur between the device manager software and its associated accessories. Bluetooth disconnections during a SmartSync patient session may lead to harm due to undesirable or incomplete...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Artis Icono Biplane. Model Number: and Artis Icono Ceiling. Model Number: and 2 more (4 items)

    Siemens Medical Solutions USA

    Why: Potential that the system may not execute movement control commands as intended and may display the following message to the user, "Limited stand/table movement, SC."

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Atellica Ch Hdl Cholesterol and Atellica Ch Total Protein_2 (2 items)

    Siemens Healthcare Diagnostics

    Why: Reagent probe carryover on the Atellica CH and Atellica CI Analyzers may cause falsely elevated Hemoglobin A1c (A1c_E/A1c_H) results due to HDLC carryover (biases of 9 29% in NGSP units), and falsely depressed Direct...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Ocs Heart Perfusion Set Model/Catalog Number: and Ocs Liver Perfusion Set Model/Catalog Number: and 1 more (3 items)

    Transmedics

    Why: The Perfusion Module may have an unprogrammed Front End Board (FEB) which will not allow the system to proceed beyond the initial startup process. The OCS system will display an error message saying Unsupported...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Ocs Liver Perfusion Set Model/Catalog Number:

    Transmedics

    Why: Incorrectly assembled device sets with incorrect accessories.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Ocs Heart System Ocs Heart Perfusion Set Model/Catalog Number: and Ocs Liver System Ocs Liver Perfusion Set Model/Catalog Number: and 1 more (3 items)

    Transmedics

    Why: Incorrectly assembled device kits that include incorrect components.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Sheehy Ventilation Tube and Bobbin Ventilation Tube (2 items)

    Medtronic Xomed

    Why: Ventilation tubes, that provide a passageway for movement of air between the auditory canal and the middle ear, were not subjected to the required sterilization process, which after implantation could cause infection...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 6, 2026

    Device recall, ongoing

    Ocs Liver System for Organ Transport Ocs Liver Perfusion Set Model/Catalog Numbe and Ocs Liver System for Organ Transport Ocs Liver Solution Infusion Set Model/Catal and 1 more (3 items)

    Transmedics

    Why: Faulty Solution Delivery System (SDS) Cassettes within the device set were assembled with syringes that were manufactured with an atypical lubricant, which results in sub-par performance and has the potential to cause...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 5, 2026

    Device recall, ongoing

    Halyard Arthroscopy Pack. Model/Catalog Number: Samm014-21.

    Avid Medical

    Why: Shelf label of kit is mislabeled as "Extremity" instead of "Arthroscopy Pack."

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 5, 2026

    Device recall, ongoing

    Liaison Plex Gram-Negative Blood Culture Assay Catalog No.

    Luminex

    Why: Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 5, 2026

    Food recall, ongoing

    Wise Wife Ground Cinnamon in Plastic Container with Black Screw Top Cap

    Slr Food Distribution

    Why: Product contains elevated levels of lead

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 5, 2026

    Food recall, ongoing

    365 Whole Foods Market Standardized + Full Spectrum Blend Ashwagandha Capsules

    Vitality Works

    Why: Possible Salmonella contamination.

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Olmesartan Medoxomil Amlodipine and Hydrochlorothiazide

    Macleods Pharma USA, sold nationwide

    Olmesartan medoxomil/amlodipine/hydrochlorothiazide tablets, 40 mg/10 mg/12.5mg, in 30-count and 90-count bottles, were recalled because they may not dissolve as required, so the body may absorb less drug than intended. Lots 12251163A and 12251163B, both expiring 05-31-2027, were sold nationwide in the USA.

    FDA reason: Failed Dissolution Specifications.

    Class II: could cause temporary or reversible harm

    In the news: 19 news outlets mentioned olmesartan in recall stories in the last two weeks.

    About 18.4 million people in the US are prescribed amlodipine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Valuhealth Extra Strength Pain Relief Acetaminophen

    Prodose, sold nationwide

    ValuHealth acetaminophen 500 mg, 40-caplet bottles, was recalled because the bottle label says Pain Relief PM instead of acetaminophen. Lot P260252, exp. 4/30/2029, was distributed nationwide in the USA.

    FDA reason: Incorrect label placed on product: Outer carton label correctly identifies drug product in bottle as ValuHealth Extra Strength Pain Relief Acetaminophen 500 mg,but inner label on bottle says ValuHealth Extra Strength...

    Class III: unlikely to cause harm

    In the news: 11 news outlets mentioned acetaminophen in recall stories in the last two weeks.

    About 6.5 million people in the US are prescribed acetaminophen each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Atorvastatin Calcium

    Msn Laboratories Private Limited (Formulations Division, Unit-Ii), sold nationwide

    Why: Presence of Foreign Tablets/Capsules

    Class II: could cause temporary or reversible harm

    About 29.7 million people in the US are prescribed atorvastatin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Formoterol Fumarate Dihydrate

    the Ritedose, sold nationwide

    Why: Failed Impurities/Degradation Specification

    Class II: could cause temporary or reversible harm

    About 1.9 million people in the US are prescribed formoterol each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Wechem Hand Guard8/1000ml Bag and Lynx and 15 more (19 products)

    Abc Compounding Co., sold nationwide

    Why: CGMP Deviations

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Metoclopramide

    Safecor Health, sold nationwide

    Why: Manufacturer is recalling batches due to co-mingled tablet.

    Class II: could cause temporary or reversible harm

    About 590,000 people in the US are prescribed metoclopramide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Lidocaine Ointment USP

    Direct Rx, sold nationwide

    Why: Subpotent Drug

    Class II: could cause temporary or reversible harm

    About 610,000 people in the US are prescribed lidocaine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Automated Impella Controller and Impella Optical Controller and 1 more (3 items)

    Abiomed, sold nationwide

    Why: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Electric Medicated Balm Ultra Strength

    Fei Fah Medical Manufacturing Pte., sold nationwide

    Why: CGMP Deviations

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Carboxymethylcellulose Sodium

    Huons Co., sold nationwide

    Why: Failed Impurities/Degradation Specification; detection of polyethylene (PE)-related oligomers

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Lidocaine

    Trifluent Pharma

    Why: Labeling: Incorrect or Missing Lot and/or Exp Date. Incorrect expiration date printed on the label.

    Not Yet Classified

    About 610,000 people in the US are prescribed lidocaine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Philips Azurion and Philips Azurion S. Model Number: (9 items)

    Philips Medical Systems Nederland B.V., sold nationwide

    Why: Solid-State Drives (SSDs) that are not specified in the Medical Device File may have been installed in various PCs. These SSDs may have different performance characteristics, which may include reduced reliability over...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Pentax Medical Ultrasound Endoscope. Model Numbers. Eg-3870utk and Pentax Medical Water Bottle Assembly. Model Number. Os-H5. and 3 more (5 items)

    Pentax of America, sold nationwide

    Why: Warnings added to the IFU for ultrasound endoscopes and water bottle assembly to ensure there is deaerated sterile water in the assembly prior to and during the procedure.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Vecuronium Bromide (2 products)

    Meitheal Pharmaceuticals, sold nationwide

    Why: Labeling: Label Lacks Warning or Rx Legend

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Theophylline Extended-Release Tablets (2 products)

    Brandywine Pharmaceuticals, sold nationwide

    Why: CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Phenylephrine HCL Infusion and Oxytocin (2 products)

    Eagle Pharma Outsourcing, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Drug recall, ongoing

    Abiraterone Acetate

    Glenmark Pharmaceuticals Inc., USA, sold nationwide

    Why: Labeling: Not Elsewhere Classified

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Omniasecure Model

    Medtronic, sold nationwide

    Why: Affected leads require additional engineering evaluation due to complaints regarding difficulty in achieving fixation during implantation. Potential harm of tissue trauma due to implant difficulty.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Alphenix Interventional Angiography System Ref: Infx-8000f and Alphenix Interventional Angiography System Ref: Infx-8000c and 1 more (3 items)

    Canon Medical System, USA, sold nationwide

    Why: Due to software issue, X-ray interventional system may experience internal error if F-Store or imagine acquisition is performed while clinical analysis function is use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Carelink Smartsync Programmer and Carelink Smartsync and 1 more (3 items)

    Medtronic

    Why: Software problem has the potential for an inaccurate displayed longevity estimate.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Nalu Td2 Therapy Disc with Firmware

    Boston Scientific Neuromodulation, sold nationwide

    Why: Therapy Disc (TD) that powers and sends stimulation signals to an Implantable Pulse Generator (IPG), part of a neurostimulation system, has a firmware issue that causes the TD to attempt to restart, then fail, leading...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Emag System Model/Catalog Number:

    Biomerieux Sa, sold nationwide

    Why: Delayed or no result when analyzing clinical samples with EMAG system (ref: 418591/418591U) due to a randomly occurring software error, Error 10003 Heater timeout after updating to recent firmware SP4 Patch 2

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Model Number:

    Philips North America, sold nationwide

    Why: Potential for the device to fail immediately after an exposure, causing the system to remain stationary.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Precision Pointer Electromagnetic

    Stryker Leibinger Gmbh & Co. Kg, sold nationwide

    Why: Device may fracture during use at the laser welded joint on the pointer tube. If this happens, loose parts may fall out of the product while the device is inside the patient.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Carevo

    Arjohuntleigh Polska Sp. Z.O.O., sold nationwide

    Why: The side support of the shower trolley may open unintentionally when the handles are not fully locked and additional force is applied during patient handling. If the side support is not fully locked and an additional...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Orthoscan Versa Accessory Cart

    Ziehm-Orthoscan, sold nationwide

    Why: The accessory cart weldment does not conform to weld dimensional specifications which may result in separation of the monitor arm mounting structure from the cart.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Ethilon Nylon Suture

    Ethicon

    Why: Nylon suture indicated for use in general soft tissue approximation and/or ligation may have needles with distorted curvature, that may break during use, or could cause additional soft tissue or vessel injury, including...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    American National Red Cross (the), Lewis and Clark Region

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were exposed to unacceptable storage temperatures, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    the American National Red Cross

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, which were not tested for pH or platelet count, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Intelerad Intelepacs Software

    Intelerad Medical Systems Incorporated

    Why: A cybersecurity vulnerability has been identified in the software that could allow a malicious user to take over an administrator session, delete or modify image or study data, or lock legitimate users out of the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 4, 2026

    Device recall, ongoing

    Senographe Pristina (3 items)

    Ge Medical Systems

    Why: GE HealthCare has become aware of a nonconformance to certain Senographe Pristina VIA systems. Specifically, in cases of 3D+2D manual mode where the acquisition configuration of the anode track/filter combination is...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Drug recall, ongoing

    Cyanocobalamin Injection

    American Health Packaging

    Why: Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.

    Class II: could cause temporary or reversible harm

    About 1.8 million people in the US are prescribed cyanocobalamin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Drug recall, ongoing

    Famotidine Injection

    Sagent Pharmaceuticals

    Why: Presence of Particulate Matter

    Not Yet Classified

    About 5.3 million people in the US are prescribed famotidine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Drug recall, ongoing

    Ciprofloxacin Tablets (2 products)

    Hikma Pharmaceuticals USA

    Why: CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

    Class II: could cause temporary or reversible harm

    About 2.5 million people in the US are prescribed ciprofloxacin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Generic Name: Perma Sharp Sutures (13 items)

    Henry Schein

    Why: Products lack 510(k) clearance.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Trusystem and Operating Table Column Ts7500 Mobius and 1 more (5 items)

    Baxter Healthcare

    Why: There is an issue with the main lift mechanism. The main lift may unexpectedly drop from its set position to its lowest position during use. In these cases, the tabletop could not be raised again after the drop...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Food recall, ongoing

    Starfish Seafood Cold Smoked Trio Salmon Halibut Trout and Starfish Seafood Cold Smoked Norwegian Salmon (2 items)

    Krasnyi Oktyabr

    Why: Contaminated with Listeria monocytogenes

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Food recall, ongoing

    Gelatelli Naturally Flavored Coffee & Vanilla Gelato with Coffee Sauce & Cookie

    Lidl US Trading

    Why: Listeria monocytogenes. The firm received positive test result of Listeria monocytogenes in the product.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    American Red Cross Biomedical Services Northern New England Region

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, lacking documentation of return to acceptable storage temperature, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    American National Red Cross

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were not tested for residual white blood cells or red blood cells (RBC) after an RBC spillover during apheresis collection, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Impactlife

    Why: Apheresis Platelets, Leukocytes Reduced, lacking documentation of acceptable storage temperature and agitation, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    New York Blood Center Enterprises

    Why: Apheresis Platelets, Leukocytes Reduced, Irradiated, which tested repeatedly reactive for anti-HCV, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Unity Knee Asc Modular Handle Included in the Corin Unity Asc Instrument System.

    Corin Medical

    Why: Potential malfunction of the Modular Handles where the locking mechanism may fail. Any mating instruments already engaged to the handle will not be able to be disengaged, and the handle will be unable to fitted securely...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Halyard Minor Pack. Model/Catalog Number: Vasf105-08.

    Avid Medical

    Why: Potential for open seals on header bags, compromising sterility.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Trusystem and Mobile Column Trusystem (2 items)

    Baxter Healthcare

    Why: The main lift may unexpectedly drop from its set position to its lowest position during use. The tabletop may not be able to be raised again after the drop occurs. An uncontrolled drop of the surgical table may result...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Trinias Opera Smart

    Shimadzu Corporation Medical Systems Division

    Why: The mounting bolts securing the C-arm drive unit of the X-ray system may not be torqued to specification, potentially compromising structural stability and safe operation.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Veritas Reverse Total Shoulder Replacement

    Restor3d

    Why: (Retroactively reported) Pairing of shoulder implant stem sizes 1 and 2 with the largest glenosphere diameter (40 mm) creates an excessive mechanical loading configuration in which certain polyethylene components lack...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Cochlear Nucleus Nexa Cochlear Implant with Contour Advance Electrode Ref P19795

    Cochlear Limited

    Why: Due to a manufacturing deviation of incomplete electrode welds of cochlear implants and resulting in one or more open circuits

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 3, 2026

    Device recall, ongoing

    Yeastone Broth

    Remel

    Why: Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 2, 2026

    Device recall, ongoing

    Cardinal Health Presource Pbds Kits (11 items)

    Cardinal Health 200

    Why: Kits contain infusion sets which were recalled for performance issues.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 2, 2026

    Device recall, ongoing

    Generic Name: Edwards Commander M Delivery System Generic Name: Edwards Commande

    Edwards Lifesciences

    Why: Due to a manufacturing issue which may result in cardiovascular balloon rupturing.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 2, 2026

    Drug recall, ongoing

    Delflex Peritoneal Dialysis Solution with (5 products)

    Fresenius Medical Care Renal Therapies Group

    Why: Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 2, 2026

    Biologic recall, ongoing

    Red Blood Cells

    Versiti Michigan

    Why: Red Blood Cells, Leukocytes Reduced, quarantined due to Whole Blood collection using a scale that did not undergo daily quality control, were distributed prior to completion of the investigation.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 2, 2026

    Drug recall, ongoing

    Tychasis Coats Aloe Lotion and Tychasis Coats Aloe Creme and 1 more (3 products)

    Biomed Laboratories

    Why: Failed Stability Specifications: OOS stability results included viscosity and appearance results that did not align with the established specifications.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Nov. 2, 2026

    Drug recall, ongoing

    Glutathione

    Premium Health Care

    Why: Microbial Contamination of Sterile Products: Out of specifications results were obtained for bacterial endotoxin.

    Not Yet Classified

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Drug recall, ongoing

    Alpha Lipoic Acid and Ascorbic Acid and 29 more (42 products)

    Victory Medical Center Pharmacy

    Victory Medical Center Pharmacy recalled alpha lipoic acid 25MG/ML 30ML, ascorbic acid 500MG/ML 50ML, preservative-free ascorbic acid 500MG/ML 50ML and B complex 30ML for lack of processing controls. Lots 2051563, 2022189 and other lots expire 10/19/2026 to 12/1/2026.

    FDA reason: Lack of Processing Controls

    Class II: could cause temporary or reversible harm

    About 300,000 people in the US are prescribed ascorbic acid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Device recall, ongoing

    Tandem Mobi Insulin Pump

    Tandem Diabetes Care

    Why: Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Device recall, ongoing

    Nextseq and Miseq Dx Instrument Ref: Dx-410-1001 / and 3 more (5 items)

    Illumina

    Why: (Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Device recall, ongoing

    Hemochron Jr.

    Accriva Diagnostics

    Why: Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Device recall, ongoing

    Evos

    Smith & Nephew

    Why: Incorrect labeling; 3.5MM Partial Articular Lateral Proximal Tibia Plate 6 hole Left 91MM implant labeled and lasered etched as as 3.5MM Lateral Proximal Tibia Plate 6 hole left 91mm implant

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Device recall, ongoing

    Embletta Mpr Pg Multi Parameter Recorder Sleep Monitor

    Natus Medical Incorporated

    Why: The device may be unable to correctly format its internal memory. When the internal memory cannot be correctly formatted, previously recorded studies may remain on the device and may be updated with incorrect patient...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Device recall, ongoing

    Cryopatch Synergraft

    Artivion

    Why: A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Drug recall, ongoing

    Fludrocortisone Acetate Tablets

    Avkare

    Why: Failed Impurities/Degradation Specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 30, 2026

    Drug recall, ongoing

    Artificial Tears Lubricant Eye Drops

    Preferred Pharmaceuticals

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 29, 2026

    Biologic recall, ongoing

    Pollens - Grasses

    Greer Laboratories

    Why: Greer Laboratories is requesting a recall for a reported phenol concentration that was recorded at a higher level than the specification limit for lot # 446661 of Standardized Sweet Vernal Grass 100,000 BAU/mL, 5mL...

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 29, 2026

    Biologic recall, ongoing

    Sterile Diluent for Allergenic Extracts Normal Saline

    Greer Laboratories

    Why: Greer Laboratories is initiating a voluntary recall of Sterile Diluent for Allergenic Extracts Normal Saline because retention samples from this lot exhibited evidence of glass delamination.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Amlodipine and Olmesartan Medoxomil

    Ascend Laboratories, sold nationwide

    Ascend recalled amlodipine/olmesartan 10mg/40mg, 30-tablet bottles because they did not dissolve as required, so the body may absorb less drug than intended. Lot # 25120696, expiring December 31, 2026, was sold nationwide in the United States.

    FDA reason: Out of specification due to dissolution.

    Class II: could cause temporary or reversible harm

    About 18.4 million people in the US are prescribed amlodipine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Brush Buddies and Evo and 3 more (17 products)

    Pritam International Private Limited, sold nationwide

    Brush Buddies and evo toothpastes, sodium fluoride 0.24% or 0.243%, 3.5- or 4.0-oz tubes, were recalled because they were not made under federal quality rules. Lots LWP240022080309, LWP250035710304C and other lots, exp. 11/30/2026 to 06/04/2028, were sold nationwide.

    FDA reason: CGMP Deviations.

    Class II: could cause temporary or reversible harm

    About 600,000 people in the US are prescribed sodium fluoride each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Levothyroxine Sodium (2 products)

    Pfizer, sold nationwide

    Levoxyl 175 mcg tablets in 100- and 1000-count bottles were recalled after testing found less active ingredient than the label states. Lots 24W06 and 24W07, expiring 11/30/2026, were sold nationwide and in Puerto Rico.

    FDA reason: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Telmisartan and Amlodipine

    Viatris, sold nationwide

    Why: Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications

    Class III: unlikely to cause harm

    In the news: 13 news outlets mentioned amlodipine in recall stories in the last two weeks.

    About 18.4 million people in the US are prescribed amlodipine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Ascorbic Acid

    Greenwich Rx, sold nationwide

    Why: Microbial Contamination of Sterile Products

    Class I: could cause serious harm or death

    About 300,000 people in the US are prescribed ascorbic acid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Vocsn and V+ Pro Emergency and 9 more (12 items)

    Ventec Life Systems, sold nationwide

    Why: Ventilator's Internal Flow transducer cable connector may disconnect from internal board, potentially resulting in system reboot and interruption of ventilation therapy.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Argatroban (2 products)

    Par Health USA, sold nationwide

    Why: Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Testosterone Cypionate

    Right Value Drug Stores, sold nationwide

    Why: Lack of sterility assurance.

    Class II: could cause temporary or reversible harm

    About 1.7 million people in the US are prescribed testosterone each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Philips Lumify Diagnostic Ultrasound System

    Philips Ultrasound, sold nationwide

    Why: Ultrasound system may: 1) Not recognize previous transducer registration, prevent scanning, require re-registration with Wi-Fi/cellular access, which may be unavailable outside of the hospital...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Medline Medical Convenience Kits Labeled As: and Medline Medical Convenience Kits Labeled As and 7 more (13 items)

    Medline Industries, sold nationwide

    Why: Reports of problems with product being difficult to remove from patient and leaving adhesive residue on patient's skin.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Heparin Sodium

    Shenzhen Techdow Pharmaceutical Co., sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Direxion Torqueable Microcatheter (41 items)

    Boston Scientific Cork, sold nationwide

    Why: The product is defective due to insufficient UV curing of the hydrophilic coating which is present on the outer surface of the distal segment of the microcatheters and raised ridges on nitinol sleeves due to laser...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Lh Lithium Heparin Separator

    Greiner Bio-One North America, sold nationwide

    Why: Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++) results which have the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Interstim Percutaneous Extensions Ext and Interstim Surescan Mri Leads (2 items)

    Medtronic Neuromodulation, sold nationwide

    Why: Wrong lead or percutaneous extension selected. Use of an incompatible lead or percutaneous extension will prevent the system from working as intended and may result in delay of surgery or need for surgical replacement...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    B Braun Safsite Injection Site

    B Braun Medical, sold nationwide

    Why: Potential for leakage and backflow at the Safsite valve.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Generic Name: Softmed Breathables Advanced Toric

    Coopervision, sold nationwide

    Why: The affected products bear an incorrect statement on the carton packaging indicating that the product is "Indicated for Extended Wear". However, this product is intended for daily wear, and the extended-wear statement...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Cinacalcet

    Strides Pharma, sold nationwide

    Why: Failed dissolution specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Medtronic Biopsy Needle Kit and Medtronic Ndi Passive Spheres Ref: (4 items)

    Medtronic Navigation

    Why: Sterile Passive spheres and biopsy needle kits contain variation in the reflective material which may affect the ability of the navigation system to detect and track the spheres.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Pne Lead Implant Kit Ref:

    Axonics, sold nationwide

    Why: Retroactively Reported: 10mL luer lock syringes included in kit may leak , break or experience other issues that may pose a risk to users.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Drug recall, ongoing

    Abiraterone Acetate

    Hikma Pharmaceuticals USA, sold nationwide

    Why: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Ion Torrent Genexus Dx with Software

    Life Technologies Holdings Pte, sold nationwide

    Why: DNA or RNA sequencing system software has vulnerabilities.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Generic Name: Minimed Go App Generic Name: Minimed Go App Model/Catalog Number

    Medtronic Minimed, sold nationwide

    Why: A software defect in which existing users who had previously configured and enabled the long-acting dose reminder feature in version 1.2.0 or earlier experienced failure of the long-acting dose reminder after updating...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Techno-Path Multichem Ae Unassayed Level and Techno-Path Multichem Ae Unassayed Level (3 items)

    Techno-Path Manufacturing, sold nationwide

    Why: A routine stability studies have identified a stability drift affecting the Ammonia (NH4+) analyte in specific lots of Multichem AE quality control material. Additional testing confirmed that the labelled shelf-life...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Rotor Assy-Sw40 and Rotor Assy-Sw41 (2 items)

    Beckman Coulter, sold nationwide

    Why: Optima XE XPN ultracentrifuge rotors may contain a microstructure defect that can cause rotors to break into two or more pieces (bifurcate) during a centrifugation run, resulting in destruction of samples being...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Carelink Clinic

    Medtronic Minimed, sold nationwide

    Why: CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Think Surgical Square Driver Ref:

    Think Surgical, sold nationwide

    Why: Robotic system square drive failed to meet design specifications potentially resulting in pin becoming stuck in square driver or the pin wobbling during drilling.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Philips Smart-Hopping

    Philips North America, sold nationwide

    Why: Unreliable wireless roaming behavior of Smart-hopping 1.0 wireless clients during transport when connecting to Smart-hopping 2.0 infrastructure, resulting in loss of connectivity to the central monitoring system (PIC...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Halyard Anterior Hip Pack. Model/Catalog Number: Soah30. and Halyard Anterior Hip Pack. Model/Catalog Number: Soah31. (2 items)

    Avid Medical, sold nationwide

    Why: A non-sterile component was piggybacked and incorrectly placed outside of the sterile barrier and not subjected to EO sterilization per kit specifications.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Amplatzer Amulet Left Atrial Appendage Occluder Model Numbers

    Abbott, sold nationwide

    Why: Changes to Instructions for Use (IFU) for the device regarding risk of Pulmonary Artery Injury (PAI).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Generic Name: Restor3d Mtp Implant Generic Name: Mtp Implant Model/Catalog Num

    Restor3d, sold nationwide

    Why: Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Device recall, ongoing

    Xact Mole Marker for Mammography Model/Catalog Number: M15rm

    Solstice, sold nationwide

    Why: The radiopaque material may detach from the marker. In some cases, artifact was noted and attributed to the detached material.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 28, 2026

    Biologic recall, ongoing

    Sterile Diluent for Allergenic Extract

    Greer Laboratories

    Why: Greer Laboratories dba Stallergenes Greer is recalling distributed Sterile Diluent for Allergenic Extracts Normal Saline due to an out of specification (OOS) phenol level (lower than expected) identified during routine...

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 27, 2026

    Drug recall, ongoing

    Cyanocobalamin Injection

    American Regent

    Why: Presence of Particulate matter: Identified as glass

    Class II: could cause temporary or reversible harm

    About 1.8 million people in the US are prescribed cyanocobalamin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 27, 2026

    Biologic recall, ongoing

    Red Blood Cells

    the American National Red Cross

    Why: Red Blood Cells, Leukocytes Reduced, collected from a donor who was deferred for accidental blood exposure, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 27, 2026

    Biologic recall, ongoing

    Pooled Platelets

    We Are Blood

    Why: Pooled Platelets, Leukocytes Reduced, Irradiated, which were not tested for pH, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 27, 2026

    Biologic recall, ongoing

    Red Blood Cells

    American Red Cross Blood Svcs

    Why: Red Blood Cells, Leukocytes Reduced, prepared from whole blood which may have exceeded the acceptable collection volume, were distributed.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 23, 2026

    Food recall, ongoing

    Eden Brothers Broccoli Seeds - Calabrese. Sold in Packets

    Eden Brothers

    Why: Salmonella

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 23, 2026

    Food recall, ongoing

    Zestigreens Broccoli Seeds for Sprouting & Microgreens

    Fortuna Marketing

    Why: Broccoli seeds potentially contaminated with Salmonella

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 23, 2026

    Food recall, ongoing

    Miyoko'S Creamery European Style Salted Plant Milk Butter

    Prosperity Organic Foods

    Why: Product recalled due to yeast, mold, and E. coli.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 22, 2026

    Drug recall, ongoing

    Amitriptyline Hydrochloride

    Avkare

    Why: Failed dissolution specifications.

    Class II: could cause temporary or reversible harm

    About 1.8 million people in the US are prescribed amitriptyline each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 22, 2026

    Food recall, ongoing

    Heirloom Homegrown Green Sprouting Calabrese Broccoli Sprouts Seed. Net Wt.

    Eak Distribution

    Why: Salmonella.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 22, 2026

    Food recall, ongoing

    Gardners Basics Brand Waltham

    Gardeners Basics

    Why: Salmonella

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 22, 2026

    Biologic recall, ongoing

    Ortho Connect

    Biomedical Data Solutions Limited

    Why: Biomedical Data Solutions is recalling distributed units of the ORTHO CONNECT software due to the software incorrectly rejecting potential discrepant results during the result review process and subsequently exporting...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 22, 2026

    Biologic recall, ongoing

    Apheresis Platelets

    Arup Laboratories

    Why: Apheresis Platelets, PAS, Leukocytes Reduced, which were labeled as leukocytes reduced but were not tested to verify residual white blood cell count and for which pH testing was not performed, were distributed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Drug recall, ongoing

    Sermorelin and Tirzepatide/Niacinamide (2 products)

    Houston Rx, sold nationwide

    Why: Lack of process control

    Class II: could cause temporary or reversible harm

    About 3.5 million people in the US are prescribed tirzepatide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Drug recall, ongoing

    Metoclopramide

    Teva Pharmaceuticals USA, sold nationwide

    Why: Presence of Foreign Tablets/Capsules

    Class II: could cause temporary or reversible harm

    About 590,000 people in the US are prescribed metoclopramide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Drug recall, ongoing

    Hydrocortisone Sodium Succinate

    Zydus Pharmaceuticals (USA), sold nationwide

    Why: Failed Impurities/Degradation Specifications.

    Class II: could cause temporary or reversible harm

    About 1.3 million people in the US are prescribed hydrocortisone each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Drug recall, ongoing

    Metoclopramide

    American Health Packaging, sold nationwide

    Why: Presence of Foreign Tablets/Capsules

    Class II: could cause temporary or reversible harm

    About 590,000 people in the US are prescribed metoclopramide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Medline Surgical Convenience Kits Labeled As: and Medline Surgical Convenience Kits Labeled As: Open Heart and 3 more (12 items)

    Medline Industries, sold nationwide

    Why: Medical convenience kits were distributed containing cannula components which do not conform to ISO 80369-7 dimensional requirements and may contribute to leaking or breaking during use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Hemosll Acustar Hit-Lgg (2 items)

    Instrumentation Laboratory, sold nationwide

    Why: Potential for invalid calibration curve or negative mean bias of up to 47% with patient samples.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Convenience Kits Containing Conmed Airseal Access Ports Advance Laparoscopic and Convenience Kits Containing Conmed Airseal Access Ports Chn Gyn Oncology D and 3 more (6 items)

    Medline Industries, sold nationwide

    Why: Kits contain CONMED AirSeal Access Ports. The ports were recalled by manufacturer due to potential for erroneous overpressure alerts and system venting during use, which may result in delays or ending procedures.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Rapicide Pa Part A High-Level Disinfectant (3 items)

    Steris, sold nationwide

    Why: If the vented cap becomes blocked, gas may accumulate and the bottle may swell due to increased internal pressure. In some cases, excess vapor or liquid chemistry may escape from the bottle when the cap is twisted...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Bd Phoenix Panel Nmic-312. Catalog Number: and Bd Phoenix Panel Nmic-306. Catalog Number: (2 items)

    Becton Dickinson &, sold nationwide

    Why: Potential for quality control failures with Klebsiella pneumoniae ATCC BAA-1705 when using the CPO Ambler classification feature.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Vinyl Instrument Guards

    Healthmark Industries Co., sold nationwide

    Why: Labeling not compliant with 21 CFR 801 and steam sterilization IFU has been updated.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Power F2 Powered Fastening System

    Ferno-Washington, sold nationwide

    Why: Firmware issue may result in intermittent loss or degradation of powered functionality when paired with compatible stretcher. The issue may lead to the system not operating in powered mode, or exhibiting reduced powered...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Grafton" Dbm and Grafton Plus" Dbm Contain Demineralized Human Bone Tissue Combi and Grafton" Dbm and Grafton Plus" Dbm Contain Demineralized Human Bone Tissue Comb (2 items)

    Medtronic Sofamor Danek USA, sold nationwide

    Why: Medtronic identified through donor record review that the donor for Medtronic batch A62881 did not meet all Medtronic donor eligibility requirements related to the presence of microbial organisms. While the batch passed...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Medline Convenience Kit Labeled As: Foot Ankle. Medline Kit Sku Dynj65395a

    Medline Industries, sold nationwide

    Why: Discrepancy in the shelf-life of a component

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Likorall Overhead Lifts Product Code:

    Baxter Healthcare, sold nationwide

    Why: Potential issue involving motor shaft breakage combined with reduced performance of the Single Fault Safety (SFS) system may lead to instances where the lift strap lowers more quickly than expected during use. Patients...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Dxu and Iq200 Sprint (2 items)

    Beckman Coulter, sold nationwide

    Why: The rinse-line check valve has a shorter service lifespan than originally expected and requires annual replacement to prevent lamina fluid leakage; however, the check valve replacement was excluded from the annual...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Generic Name: Biofire¿ Joint Infection and Generic Name: Filmarray¿ Pneumonia Panel Plus Generic Name: Filmarray¿ Pneumonia and 1 more (3 items)

    Biofire Diagnostics, sold nationwide

    Why: Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Intelepacs

    Intelerad Medical Systems Incorporated, sold nationwide

    Why: Following a Chromium-based web-browser, report and displayed images may not match.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    the Abl90 Flex and Abl90 Flex Plus Analyzers Are Intended for Use By Trained Tec

    Radiometer Medical Aps, sold nationwide

    Why: In vitro diagnostic analyzer had a risk of potentially inaccurate results requiring changes to instructions for use and: 1) Sample types, including whole blood samples no longer suitable for testing FHbF and ctBil, 2)...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Iomax Cortical Module

    Cadwell Industries, sold nationwide

    Why: Stimulator device contains a defective printed circuit board assembly (PCBA) that may cause the device to unintentionally deliver electrical stimulation to the patient, or allow an unintended electrical current to reach...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Ifuse Torq Implant System Model/Catalog Number:

    Si-Bone, sold nationwide

    Why: The pelvic fixation screws failed to meet acceptance criteria for tube packaging seal integrity testing; therefore, sterility assurance cannot be ensured.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Ref: P65 St862 Colag Screw

    In2bones USA, sold nationwide

    Why: Due to labeling error, bone screws specified as fully threaded, are actually partially threaded screws.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Jenavalve Trilogy Delivery Catheter (3 items)

    Jenavalve Technology, sold nationwide

    Why: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Mas Omni Immune Pro Liquid Assayed Integrated Immunoassay Control

    Microgenics, sold nationwide

    Why: Vial-to-vial variability in MAS¿ Omni"IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, Lot OPRO29061A results in low Parathyroid Hormone (PTH) recovery, which may lead to a delay in reporting patient...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Generic Name: Gore Viabil Short Wire Biliary Endoprosthesis

    W L Gore & Associates, sold nationwide

    Why: The potential for the devices to be mislabeled with the incorrect length.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Perma-Hand Silk Black Braided Sterile Nonabsorbable Surgical Suture

    Ethicon, sold nationwide

    Why: Silk sutures, indicated for use in cardiovascular, ophthalmic and neurological procedures, packaged with alcohol-based fluid, not part of product design, that if discovered prior to use may cause surgical delay. If...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Forward Gunshot Wound Kit

    Integrated Medcraft, sold nationwide

    Why: Subrecall of a kitted device from SafeGuard Medical due to internal testing identified an issue affecting the device's sterile pad, potentially causing the sterile pad to degrade over time. The degradation may cause...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Curaplex Capnography Etco2/O2 Oral/Nasal Cannula Multipack

    Sarnova Hc, sold nationwide

    Why: Affected kits were assembled with pediatric nasal cannula instead of the intended adult nasal cannula.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Naviflex Lw Pusher

    Boston Scientific, sold nationwide

    Why: Device was incorrectly manufactured with a guidewire exit port (referred to in the IFU as the RX port), which is not a design feature associated with this device configuration.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Neurostar Advanced Therapy System. Contains the Neurostar Hp Coil Assembly Part

    Neuronetics, sold nationwide

    Why: Cables are not in conformance with the product specifications required in the production of the HP Coil Assembly.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Food recall, ongoing

    Wild West Seeds Broccoli Seeds Green Sprouting Calabrese Lot #4105. Net Wt.

    Wild West Seed

    Why: Salmonella

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Ts Universal Baseplate Finishing Tray and Triathlon Hinge Femoral Prep Tray. Catalog Number: and 2 more (4 items)

    Howmedica Osteonics

    Why: Reprocessing instructions provided in LSTPI-B specify a sterilization dry time of 30 minutes for the trays sterilized in blue wrap. When blue wrap is used, the 30-minute dry time may lead to a small amount of residual...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Williams Cystoscopic Injection Needles

    Cook Incorporated

    Why: The female Luer lock adapter component in the affected device lots may not have been correctly seated due to misalignment and inadequate torquing during manufacturing. Potential events that may occur as a result of this...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Scout Md

    Merit Medical Systems

    Why: The implantable clip may experience difficulties deploying, which could prevent the reflector from functioning as intended during use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 21, 2026

    Device recall, ongoing

    Leadcare Ii Blood Lead Test Kit. Model/Catalog Number:

    Magellan Diagnostics, sold nationwide

    Why: In kit sub-lot 2530M-01 the date of expiration printed on the outer labeling may indicate the wrong expiration date of July 22, 2026 while the correct expiration date is July 13, 2026. If used the system will display an...

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Quad-Mix and Tirzepatide/Cyanocobalamin and 5 more (16 products)

    Carolina Infusion, sold nationwide

    Why: Lack of Assurance of Sterility: Related to processing equipment used in compounded product.

    Class II: could cause temporary or reversible harm

    About 3.5 million people in the US are prescribed tirzepatide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Tirzepatide Injection and Apothecary Nad+ Injection (2 products)

    Apothecary Pharma, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    About 3.5 million people in the US are prescribed tirzepatide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Glycerin, Hypromellose, Polyethylene Glycol 400 and Dextran 70, Polyethylene Glycol 400, Povidone, Tetrahydrozoline HCL and 5 more (8 products)

    K.C. Pharmaceuticals, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Lidocaine Ointment USP

    Preferred Pharmaceuticals, sold nationwide

    Why: Failed Content Uniformity Specifications

    Class II: could cause temporary or reversible harm

    About 610,000 people in the US are prescribed lidocaine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Ascorbic Acid:

    Centric Compounding, sold nationwide

    Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

    Not Yet Classified

    About 300,000 people in the US are prescribed ascorbic acid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Sediplast

    Polymedco, Inc. / Polymedco Cancer Diagnostic Products, sold nationwide

    Why: During use of an affected tube, the operator may encounter increased resistance when inserting the pipette. The resulting pressure buildup may cause the tube cap to detach or be forcibly ejected, potentially resulting...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Tretinoin (3 products)

    Sun Pharmaceutical Industries, sold nationwide

    Why: Failed Impurities/Degradation Specifications

    Class III: unlikely to cause harm

    About 1.7 million people in the US are prescribed tretinoin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Verify Biological Steam Test Pack Model/Catalog Number: S3065 and Verify Biological/Integrator Challenge Pack Model/Catalog Number: Lcb006 and 4 more (6 items)

    Steris, sold nationwide

    Why: Geobacillus stearothermophilus spore population in affected products may fall below minimum shelf life specification. When used to monitor steam sterilization cycles, the potential hazard is that the biological...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Battle Bandage

    Safeguard US Operating, sold nationwide

    Why: Compression bandage may be degraded, which may cause unwanted foreign material to be introduced inside the wound, which may lead to wound exploration and irrigation, formation of scar tissue, and infection.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Robotic Prostatectomy Pack and Adult Heart Tray Shands Jacks and 13 more (15 items)

    Avid Medical, sold nationwide

    Why: Product may be potentially contaminated with a lubricant used during the manufacturing process.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Epm Series Patient Monitor. Patient Monitor Series: Epm and Benevision N1 and N-Series Patient Monitor. Patient Monitor: N12/N15/N17/N19/N22 and 6 more (8 items)

    Mindray Ds USA, sold nationwide

    Why: Certain monitor operator's manuals contain descriptions that may be insufficient or may require clarification regarding selected physiological alarm functions

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Fosfomycin Tromethamine

    Cipla USA, sold nationwide

    Why: Failed Impurities/Degradation Specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Bard Ep Xt Decapolar Steerable

    Stryker Sustainability Solutions, sold nationwide

    Why: Diagnostic electrophysiology (EP) catheter may have a breached sterile barrier on the straight seal side of the primary pouch, which if used could lead to particulate embolization, infection, thrombus or ganuloma...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Minimed Flex Insulin Pump

    Medtronic Minimed, sold nationwide

    Why: Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Spectral Ct and Spectral Ct

    Philips Medical Systems, sold nationwide

    Why: Software issues may affect the safety and performance of Spectral CT system(s). The issues may result in image artifacts, wrong slice thickness, or unintended system motion.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Rollator (2 items)

    Medline Industries, sold nationwide

    Why: The front fork stem bolt/wheel assembly may disconnect from the rollator frame tubing. If the front fork stem bolt/wheel assembly disconnects from the rollator frame tubing, the front wheels may become loose or detach...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Onkos Surgical Inc. My3d Personalized Pelvic Implant (2 items)

    Onkos Surgical, sold nationwide

    Why: Personalized pelvic implants inadvertently mixed up and distributed to incorrect customers.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Nihon Kohden Cns-6200 Series Central Nurse Station

    Nihon Kohden America, sold nationwide

    Why: Due to a cybersecurity issue associate with a NULL Pointer Dereferences vulnerabiity. If exploited would potentially cause disruption of the centralized monitoring of multiple beds and the visualization of alarms.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Glypto Device

    Limitless Cryo Spa, sold nationwide

    Why: Lack of 510(k) clearance.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Hexavue Focus Integration System

    Steris, sold nationwide

    Why: A software issue may result in unintended mismatch of patient information on manually printed images. Incorrect patient information appearing on printed images could create a documentation discrepancy or incorrect...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Dxc (2 items)

    Beckman Coulter, sold nationwide

    Why: Beckman Coulter has identified a software issue affecting DxC 500i Clinical Analyzers when testing plasma samples. Following user configuration of a Clinical Chemistry test to use units different from the system...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Halyard Laparoscopy Comprehensive Pack Ii Ref:

    Gri Medical & Electronic Technology Co., sold nationwide

    Why: Laparoscopy packs labeled as "latex free" were found to contain a latex urethral catheter

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Alphenix Infx-8000c/B5

    Canon Medical System, USA, sold nationwide

    Why: Loosening of the bolts securing the longitudinal movement mechanism may cause the tabletop to shift, resulting in [positional/imaging/patient] misalignment and a longitudinal motion error

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Beach Chair Surgical Patient Positioner

    Quantum Ops, sold nationwide

    Why: Due to a manufacturing issue (inadequate weld) for patient head positioning system.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Intellijoint Navigation System: Workstation G2 Configured

    Intellijoint Surgical, sold nationwide

    Why: A navigation system used to aid in selection and positioning of orthopedic implant system components has a workstation that may contain a 15-inch MacBook Pro battery, subject to an Apple battery recall, that may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Sperm Ab Elisa

    Drg International, sold nationwide

    Why: Potential for false negative patient results.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Tuftex¿ Over-the-Wire Embolectomy Catheter

    Lemaitre Vascular, sold nationwide

    Why: Devices failed in process testing related to the amount of pull force it can sustain prior to the balloon components failing.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Nipocalimab-Aahu

    J&J Innovative Medicine

    Why: Presence of particulate matter.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Drug recall, ongoing

    Biospectra Tris/Tromethamine

    Biospectra

    Why: Failed stability specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Presource Packs Containing Medtronic Microstream Components: Intubation Kit

    Cardinal Health 200

    Why: Kits contain Microstream components. Medtronic issued an update to the Instructions for Use of these components due reports of difficulty in disconnecting the adapter from the patient's endotracheal tube to perform a...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 14, 2026

    Device recall, ongoing

    Generic Name: Kit

    Medical Action Industries, Inc. 306

    Why: An internal data-entry error caused kit lot 333606 to be labeled with an expiration date of March 31, 2027, instead of February 28, 2027.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories Mdr1070 and Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories (2 items)

    Medline Industries, sold nationwide

    Why: Potential fire hazard involving the hand control pendant and associated wiring used with affected beds. Pendant or pendant wiring may overheat, potentially leading to smoking, sparking, melting, burning, or fire....

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Ventstar Resus Neo. Neonatal.

    Draeger, sold nationwide

    Why: Potential cracks in the hose, which could lead to leakage or the hose falling off.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Drug recall, ongoing

    Estradiol Transdermal

    Amneal Pharmaceuticals, sold nationwide

    Why: Defective Container; packets were found to be either empty or partially full.

    Class II: could cause temporary or reversible harm

    About 4.1 million people in the US are prescribed estradiol each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Drug recall, ongoing

    Paroxetine Hydrochloride

    Apotex, sold nationwide

    Why: Failed dissolution specifications.

    Class II: could cause temporary or reversible harm

    About 1.7 million people in the US are prescribed paroxetine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Disposable Tourniquet Cuff and Disposable Bb Tournquet Cuff and 1 more (64 items)

    Asp Global, sold nationwide

    Why: Due to incorrect expiration date on product manufactured between September 2016 to March 2023. Products are labeled with a 10 year shelf life. The correct validated shelf life is 5 years.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Intrapulmonary Percussive Ventilation and in-Line Valve and 2 more (7 items)

    Percussionaire, sold nationwide

    Why: Labeling updated warning not to use Intrapulmonary percussive ventilation (IPV) in conjunction with volatile anesthetic delivery systems because IPV may alter controlled delivery of volatile anesthetic agents, resulting...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Drug recall, ongoing

    Benzoyl Peroxide Wash (2 products)

    Sv Labs Toronto

    Why: Microbial contamination of topical product.

    Class II: could cause temporary or reversible harm

    About 180,000 people in the US are prescribed benzoyl peroxide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Drug recall, ongoing

    Buprenorphine Hydrochloride

    Par Health USA, sold nationwide

    Why: Crystallization

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Performance Pro and Opportunity Flex and 1 more (3 items)

    American Nitrile Operations, sold nationwide

    Why: Gloves may exhibit defects such as tears, missing fingers, and debris. Use of defective gloves may lead to healthcare personnel and patient exposure to infectious pathogens leading to infection or cross-contamination...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Fisher Scientific Sure-Vue Serum/Urine Hcg and Fisher Scientific Sure-Vue Urine Hcg and 2 more (4 items)

    Alere San Diego, sold nationwide

    Why: hCG rapid tests may detect low levels of hCG below the stated assay sensitivity, which may result in false positive result.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Palacos Mv+G Pro and Palacos Mv Pro and 2 more (4 items)

    Heraeus Medical Gmbh (Dental Division), sold nationwide

    Why: Potential for monomer liquid leakage.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Ingenia and Mr and 8 more (12 items)

    Philips North America, sold nationwide

    Why: When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Quantum Pureflow Standard Heat Exchanger High Flow (2 items)

    Spectrum Medical Srl, sold nationwide

    Why: Due to blood-to-glycol leak in the heat exchanger.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Computed Tomography X-Ray System and Positron Emission Tomography and Computed Tomography System (12 items)

    Shanghai United Imaging Healthcare Co., sold nationwide

    Why: Positron emission tomography and computed tomography x-ray systems have a software problem when Split or Local function is enabled, and multiple RIS exams are merged into a single study, that prevents patient images...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Atellica Ch Revised C-Reactive Protein

    Siemens Healthcare Diagnostics, sold nationwide

    Why: The potential for falsely elevated results.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Drug recall, ongoing

    Hypromellose Eye Drops 0.7%

    Aurolab Trust

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Drug recall, ongoing

    Goserelin

    Tersera Therapeutics, sold nationwide

    Why: Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Drug recall, ongoing

    Ranolazine

    Ajanta Pharma USA, sold nationwide

    Why: Failed Dissolution Specifications: below specification

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Embosphere

    Merit Medical Systems, sold nationwide

    Why: Microspheres used in embolization of tumors, prostatic arteries, arteriovenous malformations, and blood vessels may have holes in packaging that may affect the sterile barrier, which if used could lead to infection.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Presource Packs Containing Stryker Strykeflow Ps and Ahto Tube Sets: (4 items)

    Cardinal Health 200, sold nationwide

    Why: The kits contain tube sets with handpieces that may leak during use. The impacted devices can have the following failures: fluid leakage from the hand piece that can pool on the floor. The impact can range from user...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Medical Convenience Kits Containing Bd Cliniclean Pericare Wipes Within Bd Urina (3 items)

    American Contract Systems, sold nationwide

    Why: Kits contain manufacturer-recalled perineal care (pericare) wipes within urinary catheter trays, which may be contaminated with a lubricant used during the manufacturing process. Use of a contaminated wipe may lead to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Philips Intrasight Plus Ref:

    Volcano, sold nationwide

    Why: Software system may associate image data from one patient with another patient's record, potentially resulting in incorrect diagnosis or treatment.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Mastisol Skin Adhesive

    Custom Interventional Pain Management, sold nationwide

    Why: Due to manufacturing issues with the liquid skin adhesive containing in surgical convenience trays/kits.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Penumbra System

    Penumbra, sold nationwide

    Why: Due to manufacturing issues reperfusion catheters may fracture.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Novaseq

    Illumina, sold nationwide

    Why: Retrospectively reported correction for an instrument intended for targeted sequencing of DNA libraries from human genomic DNA used with in vitro diagnostic assays has a server with a security vulnerability.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Pipeline Flex Embolization Device with Shield Technology Ref Ped2-300-12 Udi-Di

    Micro Therapeutics, sold nationwide

    Why: Due to incorrect label/product dimensions. Product is supposed to be 3.00 mm in diameter, but unit is packaging was a 2.50 mm in diameter.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Encor Encompass Breast Biopsy and Tissue Removal System Console

    Bard Peripheral Vascular, sold nationwide

    Why: Breast biopsy and tissue removal system may experience the following errors: 1) Probe calibration and /or handheld driver failure (code HH01-00020009) , 2) Pressure sensor (code E01-0054000E), which prompts the user to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Charlotte Claw Screw

    Wright Medical Technology, sold nationwide

    Why: Screws, intended for use with polyaxial compression plating system intended for foot osteotomies, was manufactured with missing threads on the screwheads, which if used would prevent a secure rigid engagement with the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Olympus Tripp-Lite P580-025

    Olympus Corporation of the Americas, sold nationwide

    Why: While in the high-power operating mode, a video dropout/blackout may occur when using a particular accessory cable.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Systems/Units Containing Affected Software/Sql Beckman Coulter Chemistry Analyz

    Beckman Coulter Mishima K.K., sold nationwide

    Why: Certain AU480 chemistry analyzers, with Windows 10 IoT Enterprise 2021 LTSC PCs, may output the message System Stopped By Fatal Error: DBConnectionError AlarmDB when launching the instrument software, using PC...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Tandem T:Slim Mobile Application Product Name: T:Slim Mobile Application

    Tandem Diabetes Care, sold nationwide

    Why: A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Noxboxi Nitric Oxide Delivery System. Model Number: Noxbox-I.

    Noxbox, sold nationwide

    Why: Potential for irregular oxygen readings due to a manufacturing issue affecting certain oxygen sensors.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Hopkins Telescope

    Karl Storz Endoscopy, sold nationwide

    Why: Due to incorrect inside packaging label for eyepiece.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Philips Medical Systems Technologies Ltd. Spectral Ct

    Philips North America

    Why: The Bolus tracking scan application may crash with a system error message. Bolus Tracker shots may continue to occur even if the contrast threshold is reached. This may result in the patient receiving additional...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Olympus M3 Gold Autoclavable Foroblique Telescope and Olympus M3 Gold Autoclavable Lateral Telescope (2 items)

    Olympus Corporation of the Americas

    Why: There are identified discrepancies between the sterilization parameters listed in the Instructions for Use and the sterilization parameters listed in the Japanese package insert.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Oct. 7, 2026

    Device recall, ongoing

    Heartsine Samaritan Pad

    Heartsine Technologies, sold nationwide

    Why: Products were distributed without the required Maintenance Supplement, which describes an extra check every 3 months in addition to the monthly check.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Imager Ii Angiographic Catheters M001314001 Imager Ii/5/St/65/038 Bx5

    Boston Scientific, sold nationwide

    Why: Tip may fracture or detach, leading to device fragments remaining within the patient or migrating through the vasculature. Patient impact may include prolonged procedure or life-threatening embolism.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Inca (2 items)

    Coopersurgical, sold nationwide

    Why: Potential to exhibit a loose connection between the flexible tubing and the nasal cannula, during assembly or while in use, which may result in loss of CPAP pressure, possibly reducing the effectiveness of treatment and...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Drug recall, ongoing

    Carboxymethylcellulose Sodium and Lubricant Eye Drops-Cameron Pharmaceuticals and 3 more (9 products)

    Sterling Pharmaceutical Services, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Halyard IV Start Kit Non-Sterile

    Avid Medical, sold nationwide

    Why: Convenience kits containing BD ChloraPrep Clear - 1 mL Applicator, which may be contaminated with Aspergillus penicillioides.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Drug recall, ongoing

    Clear Eyes Redness Relief (2 products)

    Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Drug recall, ongoing

    Olanzapine

    Macleods Pharmaceuticals Limited, sold nationwide

    Why: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

    Class III: unlikely to cause harm

    About 670,000 people in the US are prescribed olanzapine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Combiset Hemodialysis Blood Tubing Set with Attached Priming Set and Transducer

    Fresenius Medical Care Renal Therapies Group, sold nationwide

    Why: Communication to recommend reviewing the IFU and ensuring that all treatment preparation and handling steps are performed as instructed.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Achieva and Ingenia Elition S and Ingenia Elition X and 7 more (12 items)

    Philips North America, sold nationwide

    Why: A software issue will terminate an examination during the image reconstruction process if the scan parameters are manually adjusted such that reconstruction requirements exceed the available system memory.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Cardioroot Woven Collagen Coated Vascular Graft

    Intervascular, Sas, sold nationwide

    Why: Product failed to meet the specified acceptance criteria for Integral Water Permeability (IWP).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Medline Convenience Kits: (5 items)

    Medline Industries, sold nationwide

    Why: The kits contain neurological sponges with the potential for unexpected variability of endotoxin levels. Potentially elevated endotoxin levels may present health risks that could require medical intervention, such as...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Presource Convenience Kits: (2 items)

    Cardinal Health 200, sold nationwide

    Why: The kits contain applicators that may exhibit an open or incomplete seal on the packaging of the applicator. Use of a potentially contaminated applicator could result in no patient harm or may lead to localized skin or...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Foresight Elite Tissue Oximetry Cable Ref Hemfsm10 Udi-Di Code:

    Becton, Dickinson and, sold nationwide

    Why: Due to incorrect switching of Channel 1 and 2 on the module and flag labels on the tissue oximetry cables.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Drug recall, ongoing

    Exenatide

    Amneal Pharmaceuticals of New York, sold nationwide

    Why: Defective Delivery System: Possibility of no medication in the prefilled pen.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Olympus Bicoag Hemostasis Probe (4 items)

    Olympus Corporation of the Americas, sold nationwide

    Why: Potential for detachment of ceramic tip due to manufacturing without the designated amount of adhesive.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Medline Convenience Kits Containing Healthmark Instrument Channel Brushes. Sinus and Medline Convenience Kits Containing Healthmark Instrument Channel Brushes. Sin (2 items)

    Medline Industries, sold nationwide

    Why: Kits contain Healthmark Instrument Channel Brushes, which were recalled by the manufacturer due to the potential for a sharp edge/burr on the end of the brush. Potential hazards associated include cut injury/abrasion...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Midmark Iqvitals Zone (4 items)

    Midmark, sold nationwide

    Why: A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Automated Impella Controller

    Abiomed, sold nationwide

    Why: Retrospective report of issues remedied in 2019 with firmware and software patches: 1. Defects in optical bench (OPB) firmware V2.19, which affected the accuracy and stability of the pressure signal the AIC system...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Ngenuity Patient Monitor with Capnography

    Criticare Technologies, sold nationwide

    Why: Complaint trend where "Checkline Error" alarm presents at device setup, rendering the CO2 monitoring function inoperable. May result in procedure delay.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Vitek

    Biomerieux

    Why: The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Spectralis with Flex Module

    Heidelberg Engineering Gmbh, sold nationwide

    Why: Wheels may come loose when module is being pushed or pulled during movement or transportation, affecting stability of the stand. The stand may tip over as a result. Falling stand may cause impact or crushing injuries...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Ref: Hf2postd Homefill Oxygen System Homefill Cylinder D with Cga870 Compatibl and Ref:Hf2pc9 Homefill Oxygen System and 1 more (3 items)

    Ventec Life Systems, sold nationwide

    Why: Labeling; Oxygen Cylinders do not contain required medical gas labeling

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    New York Embroidery Studio Trinity Non-Surgical Isolation Gown

    New York Embroidery Studio, sold nationwide

    Why: Gowns do not consistently meet the minimum liquid-barrier performance required.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Ref:

    Deroyal Industries, sold nationwide

    Why: Myocardial temperature probes contain an incorrect needle. Specifically, an 18mm needle was included instead of a 15mm needle.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Pro+ and Pro+ Mrs Surface for Versacare (3 items)

    Baxter Healthcare, sold nationwide

    Why: There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Halyard IV Start Kit Non-Sterile (2 items)

    Avid Medical, sold nationwide

    Why: Convenience kits containing BD ChloraPrep Clear - 1 mL Applicator, which may exhibit an open or incomplete seal on the packaging of the applicator.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Contact Lens

    Coopervision, sold nationwide

    Why: A small number of lenses within the affected lot are of the incorrect power.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Powerled

    Maquet Sas, sold nationwide

    Why: The potential for the device to detach at the junction between the spring arm and suspension arm and fall causing potential injury.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Philips Epiq Elite Diagnostic Ultrasound System Model #

    Philips Ultrasound, sold nationwide

    Why: Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Extended Polyaxial Head

    Seaspine Orthopedics, sold nationwide

    Why: The proximal thread depth of the spinal device is out of design specification.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Volara

    Baxter Healthcare, sold nationwide

    Why: Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to firm and testing confirmed devices meet specifications.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Drug recall, ongoing

    Menow Sunscreen Pressed Powder Spf35 Pa+++

    Shantou Qiwei Industrial Co.

    Why: cGMP Deviations

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 30, 2026

    Device recall, ongoing

    Olympus Ezdilate Endoscopic Balloon Dilator Wired-Guided

    Olympus Corporation of the Americas

    Why: Potential for the inflation chart label affixed to the shaft of the device to be incorrect and indicate a balloon diameter of 18, 19, or 20 mm,

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Thyroid

    Vitruvias Therapeutics, sold nationwide

    Why: Superpotent Drug

    Class I: could cause serious harm or death

    About 1.2 million people in the US are prescribed thyroid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Chlorthalidone

    Inventia Healthcare Limited, sold nationwide

    Why: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    About 1.3 million people in the US are prescribed chlorthalidone each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Medline Convenience Kits: (7 items)

    Medline Industries, sold nationwide

    Why: The kits contain certain lots of sterile applicators which may contain fungal contamination that may occur under certain environmental conditions, allowing the growth of Aspergillus penicillioides. Contamination of skin...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Statstrip Glucose and B- Ketone Meter. Model No: and Statstrip Glucose Hospital Meter System. Model No: (5 items)

    Nova Biomedical, sold nationwide

    Why: A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID)...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Lidocaine

    Sun Pharma /Taro, sold nationwide

    Why: Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

    Class II: could cause temporary or reversible harm

    About 610,000 people in the US are prescribed lidocaine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Automated Impella Controller and Impella Optical Controller with the Below Product Descriptions and Corresponding and 1 more (3 items)

    Abiomed, sold nationwide

    Why: The potential for purge cassette recognition issues due to the failure of the purge flag component of the purge pressure sensor assembly.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Power-Trialysis Short-Term Straight Dialysis Catheter and Duoglide Short-Term Straight Dialysis Catheter (2 items)

    Bard Access Systems

    Why: this is a downstream recall of class I recall RES 98777

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Bd Alaris Pump Infusion Sets

    Bd Switzerland Sarl

    Why: Due to discrepancies in specific attributes in the performance data for infusion sets, which may lead to inappropriate pump performance.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Ref:2b5st Ethicon Endo-Surgery and Ref:B5st Ethicon Endo-Surgery and 4 more (6 items)

    Stryker Sustainability Solutions, sold nationwide

    Why: Reusable access port system may crack or seperate during use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Oncology Sets with Drip Chambers and IV Sets with Drip Chambers and 2 more (8 items)

    Icu Medical, sold nationwide

    Why: Intravascular administration tubing set drip chambers may have black specks potentially due to the plastic molding process leaving discolored polyvinyl chloride (PVC) material within the drip chamber wall that does not...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Scorpio C-Dome Patella 73-2710 73-2910 Scorpio U-Dome Patella 73-311 and Abg I Acetabular Insert Hooded and 10 more (12 items)

    Howmedica Osteonics, sold nationwide

    Why: Affected devices were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five years. Product has the potential for elevated levels of oxidation, which may result in...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Halyard IV Start Kit Non-Sterile Ref: Kriv26-02

    Avid Medical, sold nationwide

    Why: Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which are contaminated with Aspergillus penicillioides

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Haylard and Haylard Univ Imaging Biopsy Trucustom and 2 more (4 items)

    Avid Medical

    Why: Potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Hemospray Endoscopic Hemostat

    Wilson-Cook Medical, sold nationwide

    Why: Due to issue with endoscope adherence and inability to spray powder. Firm will provide an updated Instruction for Use (IFU).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Percutaneous Insertion Kit (3 items)

    Maquet Cardiopulmonary Gmbh, sold nationwide

    Why: The packaging may not consistently maintain sterile barrier integrity.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Cadd Yellow Medication Cassette Reservoir with Nrfit Connector US Product Cod

    Icu Medical, sold nationwide

    Why: Reservoirs may exhibit medication leakage at the joint between luer connector and tubing. Issue could result in delay or interruption of therapy, under delivery of medication, exposure to infectious or toxic agents, or...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Fluphenazine HCL Elixir (6 products)

    Safecor Health, sold nationwide

    Why: Failed Stability Specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Carescape Central Station Cscs V3 Mas800 Desktop Part Number

    Ge Medical Systems Information Technologies, sold nationwide

    Why: Device may not resume patient monitoring for at least 3 minutes following system restart. Issue can lead to potential delay in recognition of clinically significant events.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Happiest Baby (2 items)

    Happiest Baby, sold nationwide

    Why: Extra small (ES) and Extra-large (XL) infant sleep sacks have not been reviewed for safety and effectiveness by the FDA.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Centricity Pacs Server V7 and Centricity Pacs V2 and 4 more (6 items)

    Ge Healthcare, sold nationwide

    Why: Under certain conditions historical imaging data migrated from a legacy system may become incorrectly associated with a different patient. If this occurs, studies or images may be displayed under the wrong patient...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Medrad¿ Stellant Flex Syringe Kit Used with Stellant Flex Ct Injection System

    Bayer Medical Care, sold nationwide

    Why: Some devices may not have been properly sterilized due to a manufacturing sterilization issue.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Sunmed Tracheal Tube

    Well Lead Medical Co., sold nationwide

    Why: The 6Fr suction catheter could not pass through the samples smoothly.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Drug recall, ongoing

    Dopamine Hydrochloride

    Pfizer, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Aisys Cs2 with Et Control and Et Control and 2 more (4 items)

    Datex-Ohmeda, sold nationwide

    Why: Anesthesia Delivery Systems containing certain electronic gas mixer assemblies can automatically transition to Alternate O2 control. In Alternate O2 control, the system delivers 100% O2 to the breathing system enabling...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Medline Convenience Kit: Open Heart A Pack

    Medline Industries, sold nationwide

    Why: The kits contain a Retrograde Coronary Sinus Perfusion (RCSP) cannulae that has the potential for a sterile barrier breach. Sterility of the product cannot be assured. If a compromised pouch seal is not identified prior...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Philips Pic Ix Essentials Ref:867093 and Philips Patient Information Center Ix Ref:866389 (2 items)

    Philips North America, sold nationwide

    Why: Due to software malfunction, patient information system may freeze and become unresponsive.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Reign Medical Clench Staple System

    F & A Foundation, sold nationwide

    Why: Bone fixation staple requires a new 510(k); the performance characteristics of this device have not been adequately established.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Captus

    Mirion Technologies (Capintec), sold nationwide

    Why: Potential for failure of the tension bolt which would allow the spring arm to unexpectedly fall to its lowest position, which is approximately 25 inches (63.5 cm) from the ground.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Pi-Cardia Inc. Shortcut Ref: Z-A-20.003-US

    Pi Cardia, sold nationwide

    Why: Transfemoral catheter, positing arm may detached due to weld issue.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Boston Scientific Corporation Stonesmart Connect Console Contents:

    Boston Scientific, sold nationwide

    Why: A subset of power adapters used with the connect console may exhibit higher-than-expected resistance in the electrical grounding path. As a result, the power adaptor may fail electrical safety testing during...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Convenience Kits Myringotomy Pack-Lf Dynj59097a and Convenience Kits Anesthesia Pain Pk League Dynj67925a and 2 more (4 items)

    Medline Industries, sold nationwide

    Why: Kits may exhibit open seals in sterile pouch packaging. Open seal may compromise product sterility. If not detected prior to use, issue may lead to contamination of sterile field or patient infection if product is used.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Noxboxi Nitric Oxide Delivery System.

    Noxbox, sold nationwide

    Why: Potential for oxygen tubing leaks due to failure of the tubing or tubing connection, which may lead to oxygen desaturation.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Rt Montecarlo

    Ptw Freiburg, sold nationwide

    Why: When a bolus is included in a treatment plan and sent for secondary dose calculation, the software accounts for it but does not display this clearly, which may lead users to incorrectly omit the bolus during treatment...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Ewo_02512 and Ewo_02513 (2 items)

    Embecta Medical Ii, sold nationwide

    Why: Retrospectively reported: Pen needles labeled 'For Investigational Use Only' were inadvertently distributed as commercially marketed devices.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Gm Helix Implant

    Straumann USA, sold nationwide

    Why: There is a discrepancy between the product identification on the packaging and the dimensions of the implant contained inside.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Kinos Axiom Total Ankle System with Axiom Psr

    Restor3d, sold nationwide

    Why: Ankle implantation systems were packaged with incorrect patient-specific cutting guides, which may result in: delayed surgery, the need to use standard instrumentation, reduced fixation or poor alignment of implants...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Dash Rapid Pcr Instrument

    Nuclein, sold nationwide

    Why: Due to a software issue

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 23, 2026

    Device recall, ongoing

    Blood Culture Collection Venipuncture Kit

    Medical Action Industries, Inc. 306, sold nationwide

    Why: Blood culture convenience kits contain a component subject to a drug recall that due to an an open or incomplete seal on the packaging of the applicator may compromise the component's sterile barrier and if used may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Epinephrine

    American Regent, sold nationwide

    Why: Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

    Class I: could cause serious harm or death

    About 1.1 million people in the US are prescribed epinephrine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Sodium Chloride

    B Braun Medical, sold nationwide

    Why: Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Bravo Cf Capsule Delivery Device

    Given Imaging, sold nationwide

    Why: Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Dextrose Injection

    Baxter Healthcare, sold nationwide

    Why: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Products That Contain the Pericare Wipes: Surestep" Foley Tray System Add-A-Fol and Products That Contain the Pericare Wipes: Bard¿ Foley Tray with Lubri-Sil¿ All- and 4 more (6 items)

    C.R. Bard, sold nationwide

    Why: Due to complaints received indicating presence of contamination on the surface of pericare wipes provided with various Foley and Intermittent Catheter Trays.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Kit: Single Shot Epidural and Kit: Epidural/Pain Tqc (2 items)

    Medical Action Industries, Inc. 306

    Why: Kits containing Sodium Chloride ampules subject to another recall are recalled due to potentially compromised sterility.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Medicalyte Liquid Bicarbonate Concentrate Ref: Bc-100 and Bc+201 and Citric Complete Liquid Citric Acid Concentrate Ref: Lc+200-D and 2 more (4 items)

    Nipro Renal Soultions USA, sold nationwide

    Why: Hemodialysis concentrates contain high endotoxin levels

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Heartsine Sam

    Heartsine Technologies, sold nationwide

    Why: Due to a damaged (over stretched) membrane tail that causes an intermittent fault.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Fentanyl Citrate

    Ourpharma, sold nationwide

    Why: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Fluphenazine Hydrochloride

    Ajanta Pharma USA, sold nationwide

    Why: Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Dermav Laser System

    Lutronic, sold nationwide

    Why: Utilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in patient burn.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Getinge Pvc Thoracic Catheter (3 items)

    Atrium Medical, sold nationwide

    Why: An Out of Specification result (OOS) related to bacterial endotoxin testing in a single lot of catheters.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Ams Convenience Kit: Dsaek Pack - Rx

    Windstone Medical Packaging, sold nationwide

    Why: The convenience kits contain .0.9% Sodium Chloride Injection, USP products in Single Dose freeflex bags, which may contain blue Break-off-Parts (BOPs) that have detached from the infusion port during manipulation.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Device recall, ongoing

    Halyard IV Start Kit Non-Sterile Ref: Kriv26-02

    Avid Medical, sold nationwide

    Why: Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which lacks sterility assurance due to to wrinkles in the paper lidding which may breach the seal area.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 16, 2026

    Drug recall, ongoing

    Povidone Iodine

    Imprimisrx Nj, sold nationwide

    Why: Subpotent Drug

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Clindamycin Phosphate and Vasopressin and 8 more (17 products)

    Baxter Healthcare, sold nationwide

    Why: CGMP Deviations

    Class II: could cause temporary or reversible harm

    About 2.6 million people in the US are prescribed clindamycin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Trazodone Hydrochloride

    Teva Pharmaceuticals USA, sold nationwide

    Why: Presence of Foreign Tablets/Capsules

    Class II: could cause temporary or reversible harm

    About 6.4 million people in the US are prescribed trazodone each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Ascorbic Acid

    Optimal Balance Pharmacy, sold nationwide

    Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

    Class I: could cause serious harm or death

    About 300,000 people in the US are prescribed ascorbic acid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Chlorhexidine Gluconate

    Sage Products, sold nationwide

    Why: Cross Contamination with Other Products

    Class II: could cause temporary or reversible harm

    About 960,000 people in the US are prescribed chlorhexidine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Sodium Chloride

    Baxter Healthcare

    Why: Presence of particulate matter: Particulates identified as fiberglass

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Mycophenolate Mofetil

    Mylan Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    About 160,000 people in the US are prescribed mycophenolate mofetil each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Topiramate) Extended-Release Capsules

    Supernus Pharmaceuticals, sold nationwide

    Why: Failed dissolution specifications.

    Class III: unlikely to cause harm

    About 2 million people in the US are prescribed topiramate each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Medline Convenience Kits: (16 items)

    Medline Industries, sold nationwide

    Why: The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Medline Convenience Kits Containing Bd Chloraprep Clear - (13 items)

    Medline Industries, sold nationwide

    Why: Convenience kits contain BD ChloraPrep Clear - 1mL Applicators from specific lots that were recalled by the manufacturer because they may have an open or incomplete seal on the applicator packaging. Use of potentially...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Healon Endocoat Pro

    Johnson & Johnson Surgical Vision, sold nationwide

    Why: Surgical instructions sent for viscoelastic products used during ophthalmic viscosurgical cataract procedures including in part: If resistance is encountered during insertion, withdraw cannula and reassess the insertion...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    the One Spf (4 products)

    Allies Group, sold nationwide

    Why: Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Prasugrel

    Mylan Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Halyard Medical Convenience Kits Labeled As: and 1) Neuro (3 items)

    Avid Medical, sold nationwide

    Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Presource Packs Containing Cliniclean Pericare Wipes Within Bd Urinary Catheter (12 items)

    Cardinal Health 200, sold nationwide

    Why: The Urinary Catheter Trays contain CliniClean Pericare Wipes which may potentially be contaminated with a lubricant used during the manufacturing process. If a contaminated wipe is used on a patient, localized skin...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    5008x Hd/Hdf with Twister Blood Tubing Set Part Number and 5008x Standard Hd Pre-Flush Standard Blood Tubing Set Part Number and 2 more (4 items)

    Fresenius Medical Care Renal Therapies Group, sold nationwide

    Why: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Granuflo Dry Acid Concentrate: Product Numbers: and Naturalyte and 1 more (3 items)

    Fresenius Medical Care Renal Therapies Group, sold nationwide

    Why: Complaints of blue-green discoloration in product

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Baxter Novum Iq Syringe Pump (2 items)

    Baxter Healthcare, sold nationwide

    Why: A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Discofix Four Way Stopcock

    B Braun Medical, sold nationwide

    Why: Specific lots of Discofix Stopcock Sets recalled due to an incorrect expiration date printed on the carton shipper label.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Doxylamine Succinate and Pyridoxine Hydrochloride

    Bionpharma, sold nationwide

    Why: Presence of Foreign Tablets/Capsules

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Prasugrel

    Golden State Medical Supply, sold nationwide

    Why: Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Sta Staclot Protein S

    Diagnostica Stago, sold nationwide

    Why: A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Lux-Dx (3 items)

    Boston Scientific, sold nationwide

    Why: There is potential for a delay in AF Burden Alert notification affecting the server software which supports the Insertable Cardiac Monitors (ICMs). Delayed notification of an AF Burden Alert may delay clinical...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Velys Enabling Tech Robotic-Assist Station Ref:

    Medos International Sarl, sold nationwide

    Why: Software issue within robotic controller which may cause unintended movement of the robotic arm during bone preparation or instrument positioning.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Buprenorphine

    American Health Packaging, sold nationwide

    Why: Labeling: Label Mix-up

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Broadway Joe'S Pain Cream (2 products)

    Lexia

    Why: CGMP Deviations: Potential contamination of raw material

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Device recall, ongoing

    Philips Brilliance Ct and Philips Ingenuity Ct Product Codes: Ingenuity Ct Upgrades and 2 more (4 items)

    Philips North America

    Why: Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 9, 2026

    Drug recall, ongoing

    Elapegademase-Lvlr

    Chiesi USA

    Why: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Levothyroxine Sodium (12 products)

    Accord Healthcare, sold nationwide

    Accord recalled 25, 50, 125 and 200 mcg levothyroxine tablets in 1000-count bottles, and 200 mcg in 90-count bottles, after tests found less active ingredient than labeled. Lots D2402430, D2402431 and other lots, expiring 08/31/2026 to 01/31/2027, went nationwide.

    FDA reason: Subpotent Drug

    Class II: could cause temporary or reversible harm

    About 19 million people in the US are prescribed levothyroxine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride

    B Braun Medical, sold nationwide

    Why: Presence of Particulate matter.

    Class I: could cause serious harm or death

    About 4.1 million people in the US are prescribed potassium chloride each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Ramipril

    Hikma Pharmaceuticals USA, sold nationwide

    Why: Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

    Class II: could cause temporary or reversible harm

    About 440,000 people in the US are prescribed ramipril each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Clobetasol Propionate

    Lupin Pharmaceuticals, sold nationwide

    Why: Failed content uniformity specifications.

    Class II: could cause temporary or reversible harm

    About 2.2 million people in the US are prescribed clobetasol each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Paroxetine

    Apotex, sold nationwide

    Why: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria

    Class II: could cause temporary or reversible harm

    About 1.7 million people in the US are prescribed paroxetine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Tocilizumab-Aazg

    Fresenius Kabi USA, sold nationwide

    Why: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Zicam

    Church & Dwight Co., sold nationwide

    Why: CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Medline Breathing Circuits Labeled As: and Medline Hudson Rci (3 items)

    Medline Industries, sold nationwide

    Why: Neonatal and infant heated wire breathing circuits may experience sporadic failure. The heated wire connector (pigtail) at the humidifier may exhibit discoloration, melting, smoke, burning odor, or other signs of...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Onli

    Hollister Ulc, sold nationwide

    Why: Hollister has identified that select lots of the catheters identified in the above table may exhibit a protrusion caused by a manufacturing defect which might lead to genitourinary trauma or bleeding.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Drug recall, ongoing

    Acthar Gel

    Mallinckrodt Hospital Products, sold nationwide

    Why: Presence of particulate matter: glass and stopper piece

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Medline Convenience Kits Labeled As: and Medline Convenience Kits Labeled As: Ltp Cds-Lf and 1 more (11 items)

    Medline Industries, sold nationwide

    Why: Kits contain a potentially contaminated component which were recalled by the manufacturer

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Halyard Total Joint Model/Catalog Number: Msbm036-03 and Davinci Trucustom Bundle Containing Tray Foley (7 items)

    Avid Medical, sold nationwide

    Why: Labeling Deficiency: The medical kit labeling fails to identify that the statlock component contains natural rubber latex.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Ort200 and Ort300 (2 items)

    Imris Imaging, sold nationwide

    Why: The linear actuator and rotational lock mechanism components may experience a mechanical failure that prevents the system from transitioning between locked and unlocked state. This may pose a risk of injury to the...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Powerseal

    Olympus Corporation of the Americas, sold nationwide

    Why: Potential labeling deficiency in which an outer shelf box is incorrectly labeled as a 37-cm device.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Fresenius Medical Care

    Fresenius Medical Care Renal Therapies Group, sold nationwide

    Why: Fresenius Medical Care Renal Therapies Group, LLC (FMCRTG) has received complaints regarding flow-, no water-, or temperature-related alarms with the 2008T¿ BlueStar Hemodialysis machines.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Merge Pacs and Merge Orthopacs

    Merge Healthcare, sold nationwide

    Why: Software issue may cause measurements to be displayed inaccurately.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Alphenix Models Infx-8000c Infx-8000f Infx-8000v This Device Is A Digital

    Canon Medical System, USA, sold nationwide

    Why: Due to the fixing screws of ceiling movement gear in ceiling suspended arm that are part of the X-ray interventional systems may become loose.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Medline Medical Convenience Kits (4 items)

    Medline Industries, sold nationwide

    Why: Specific item(s) and lot(s) of Medline convenience kits containing Pilling Wecksorb Neurosponges and Neurosponge Strips are being recalled due to potential out-of-specification levels of endotoxin of the neurosponges.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    American Contract System Convenience Kit and American Contract System Convenience Kits (4 items)

    American Contract Systems, sold nationwide

    Why: The Convenience Kits contain Medline's Red Rubber Intermittent Catheters (8Fr-22 Fr) and Red Rubber Intermittent Catheter Trays. Medline Industries, LP has identified representative samples did not meet applicable...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Medline Medical Convenience Kit Labeled As: Trach Tube Kit

    Medline Industries, sold nationwide

    Why: Component labeling discrepancy

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Midmark Digital Ecg Hd+12 and Midmark Iqecg Digital Ecg (2 items)

    Midmark, sold nationwide

    Why: A communication anomoly may result in incorrect electrocardiogram waveforms of a patient and an inaccurate beats-per-minute calculation.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Structur and Grandio Universal Nano-Hybrid Restorative Material - Capsules (2 items)

    Henry Schein, sold nationwide

    Why: Specific lots were distributed in the US with incorrect packaging and Instructions for Use (IFU) from the U.S. FDA-cleared device.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Conmed Linvatec Genesys Crossft Suture Anchor with Disposable Driver Ref# Cfbc

    Conmed, sold nationwide

    Why: Suture anchor may contain incorrect patient implant card which may result in incorrect device identification and traceability.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Healthmark Prochek-Ii and Healthmark Prochek-W Protein Test for Robotic Arms (2 items)

    Healthmark Industries Co., sold nationwide

    Why: Test manufactured with an expired ingredient which may present as either a false negative or positive.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Fujifilm Synapse Pacs Software V7.4.310

    Fujifilm Healthcare Americas, sold nationwide

    Why: Software issue may cause the ruler measurement to be inaccurate.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Philips Incisive Ct with Software V4.5&V5.0

    Philips Healthcare (Suzhou) Co., sold nationwide

    Why: Potential of failing to trigger clinical scan during Bolus Tracking.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Sept. 2, 2026

    Device recall, ongoing

    Portrait Core Services Software V1.0.5 and Portrait Compute and Core Services V1.2 and 2 more (4 items)

    Ge Medical Systems Information Technologies

    Why: Software issue may result in a loss of patient monitoring at the Hub and Central Viewer. In addition, all alarm settings could be reset to factory defaults following the update and will not follow the alarm settings...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Cyanocobalamin and Trace Elements Injection 4 and 7 more (12 products)

    American Regent, sold nationwide

    Cyanocobalamin 10,000 mcg/10 mL, Multrys (Trace Elements Injection 4), acetylcysteine 20%, and papaverine 60 mg/2 mL vials were recalled because particles were found. Lots 25082, 25163 and other lots, expiring 9/30/2026 to 8/31/2027, were sold nationwide in the U.S.

    FDA reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

    Class I: could cause serious harm or death

    About 1.8 million people in the US are prescribed cyanocobalamin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Morphine Sulfate

    Fresenius Kabi USA, sold nationwide

    Why: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

    Class I: could cause serious harm or death

    About 590,000 people in the US are prescribed morphine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Boston Scientific Enroute Transcarotid Neuroprotection System Plus and Boston Scientific Enroute Transcarotid Neuroprotection System (2 items)

    Boston Scientific, sold nationwide

    Why: Potential for arterial sheath tip separation or partial tip separation during use.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Carbamazepine Tablets

    Golden State Medical Supply, sold nationwide

    Why: CGMP deviations: tablets with black specks.

    Class II: could cause temporary or reversible harm

    About 420,000 people in the US are prescribed carbamazepine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Carbamazepine Tablets

    Sun Pharmaceutical Industries, sold nationwide

    Why: CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

    Class II: could cause temporary or reversible harm

    About 420,000 people in the US are prescribed carbamazepine each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Bmc/Reacthealth Luna G3 Apap Ref Lg

    Bmc Medical Co.

    Why: Retroactive reporting for 2024 rework conducted at the 3B/React Health warehouse

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Bd Needle Kit for Powered Driver

    Bard Access Systems

    Why: After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Overstitch Suture Cinch and Suture Cinch Long (2 items)

    Boston Scientific, sold nationwide

    Why: Device may fail to deploy the cinch implant and/or fail to cut the suture as intended.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Esteem Body Soft Convex Urostomy Pouch Model/Catalog Numbers:

    Convatec, sold nationwide

    Why: Urostomy Pouches may leak from cap during use.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Pemetrexed Disodium (2 products)

    Shilpa Medicare Limited, sold nationwide

    Why: Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Cemiplimab-Rwlc

    Regeneron Pharmaceuticals, sold nationwide

    Why: Lack of Assurance of Sterility

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    One-Piece Guedel Airway (2 items)

    Intersurgical, sold nationwide

    Why: Devices could potentially be occluded or partially occluded.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Drug recall, ongoing

    Acamprosate Calcium Enteric-Coated

    Mylan Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Halyard Lavh Pack

    Avid Medical, sold nationwide

    Why: The kit component was subjected to EO sterilization, contrary to the manufacturer recommendation, which may have led to the component leaking in a kit.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Beckman Coulter and Syva Emit (2 items)

    Siemens Healthcare Diagnostics, sold nationwide

    Why: Due to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Blanketrol Ii Model and Blanketrol Iii and 1 more (3 items)

    Gentherm Medical, sold nationwide

    Why: Overheating of the 115V CPU board may cause the device to shut down.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Veritas Standard Glenoid Baseplate

    Restor3d, sold nationwide

    Why: Due to incorrect machining of peripheral screw hole resulting in potential for improper engagement of the peripheral screws.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Paragonix Technologies Inc. Kidneyvault Portable Renal Perfusion System Ref# Pr

    Paragonix Technologies, sold nationwide

    Why: Due to a firmware defect, the portable organ transfer device datalogger may lose its configuration, resulting in a blank screen and loss of displayed preservation parameters.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Td Navio Midi Speech Generating Device Model/Catalog Number: and Td Navio Maxi Speech Generating Device Model/Catalog Number: (2 items)

    Tobii Dynavox, sold nationwide

    Why: Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Hamilton Microlab Star Liquid Handler

    Foundation Medicine, sold nationwide

    Why: Software issue that can cause an increase in spontaneous software closures.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Cardiac Workstation (2 items)

    Philips North America, sold nationwide

    Why: Device will intermittently provide inaccurate data related to native heart rate.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Siemens Healthineers Immulite (2 items)

    Siemens Healthcare Diagnostics Products, sold nationwide

    Why: Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Endoflip System That Includes: Endoflip

    Covidien, sold nationwide

    Why: The system's 24-hour usage limit results in catheters incorrectly flagged as expired, making them unavailable for clinical procedures.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Beckman Coulter Dxc (2 items)

    Beckman Coulter, sold nationwide

    Why: a software defect in which the Parameter Package (PP) import logic overwrites all predefined calculated test rules, including those previously modified by the user, upon import of a new Parameter Package version. As a...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Fort Defiance Industries

    Fort Defiance Industries, sold nationwide

    Why: The Automated Field Steam Sterilizer's water recovery system 120V Amphenol connector may experience an intermittent loss of ground continuity, which could result in an unreliable fault current return path.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Arrow-Lok Implant

    Arrowhead De, sold nationwide

    Why: Implant did not undergo required gamma radiation dose audit. A potential reduction in sterility assurance could lead to patient infection.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Getinge Y Sensor Module

    Maquet Critical Care Ab, sold nationwide

    Why: The module did not undergo electrical safety tests and functional tests during production.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    American Contract Systems Medical Procedure Kits and Trays Labeled As: (2 items)

    American Contract Systems

    Why: The recall notice was initiated due to a Medicom Urgent Medical Device Recall. Medicom is recalling specific lots of Ritmed¿ Neurological Sponges Non-Sterile Models 55992C to 55998C due to potential for unexpected...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Arvis Surgical Navigation System Gen

    Kico Knee Innovation

    Why: Due to an internal sensor issue, image displayed with eyepiece may appear tilted relative to the eyepiece housing

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Minimed (3 items)

    Medtronic Minimed

    Why: Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Lago X and Ami Htx (2 items)

    Spectral Instruments

    Why: Momentary absence of On-Screen "X-Ray On" banner during run readiness check.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Dentsply Sirona Capsule Mixer Model No.

    Sdi Limited

    Why: Potential for electrical discharge from unit when unplugged.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 26, 2026

    Device recall, ongoing

    Custom Made Device Implant (2 items)

    Paragon 28, sold nationwide

    Why: Device was recalled due to an elevated oxygen level in excess of the allowable limit. Elevated oxygen levels may contribute to reduced material ductility.

    Class III: unlikely to cause harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Semaglutide (11 products)

    Apollo Care, sold nationwide

    Apollo Care recalled semaglutide 7.5 mg, 12.5 mg, 2.25 mg and 2.5 mg sterile multi-dose vials (1.5, 5 or 2.5 mL) after finding foreign particles. Lots AC-017273, AC-017108 and other lots, expiring 8/30/2026 to 5/5/2027, were sold nationwide.

    FDA reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

    Class II: could cause temporary or reversible harm

    About 8.3 million people in the US are prescribed semaglutide each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Sildenafil Citrate USP and Tadalafil USP (5 products)

    Shoolin Pharma Chem L, sold nationwide

    Why: CGMP Deviations:Noted during FDA inspection

    Class II: could cause temporary or reversible harm

    About 1.4 million people in the US are prescribed tadalafil each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Glutathione

    Victory Medical Center Pharmacy, sold nationwide

    Why: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

    Class I: could cause serious harm or death

    About 300,000 people in the US are prescribed ascorbic acid each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Clindamycin Palmitate Hydrochloride

    Heritage Pharmaceuticals, sold nationwide

    Why: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

    Class II: could cause temporary or reversible harm

    About 2.6 million people in the US are prescribed clindamycin each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Valsartan

    Novartis Pharmaceuticals, sold nationwide

    Why: Failed Dissolution Specifications

    Class II: could cause temporary or reversible harm

    About 2.6 million people in the US are prescribed valsartan each year.

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Cefazolin in Dextrose

    Baxter Healthcare, sold nationwide

    Why: Presence of Particulate Matter

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Baxter Duo-Vent Solution Set and Male Luer Lock Adapter

    Baxter Healthcare, sold nationwide

    Why: Baxter received customer reports of air bubbles in the drip chamber and tubing when a pressure cuff is in use or when the tubing is flushed at the fully open position.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Ioversol

    Liebel-Flarsheim Company, sold nationwide

    Why: Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Cardinal Health Presource Kits: (8 items)

    Cardinal Health 200, sold nationwide

    Why: Procedure kits contain MEDICOM Ritmed Neurological Sponges that were recalled due to unexpected variability in endotoxin levels.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    V-Loc and Surgipro Ii S8698gx Surgipro Ii Bl and 2 more (5 items)

    Covidien, sold nationwide

    Why: Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Kian Pee Wan Capsules

    Buy-Herbal

    Why: Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Medline Micro-Kill Bleach Germicidal Bleach Wipes (4 items)

    Medline Industries, sold nationwide

    Why: Medline Micro-Kill Bleach Germicidal Bleach Wipes may exhibit a reduction in bleach concentration to levels below specification prior to the end of the labeled 12-month shelf life. Reduced bleach concentration may...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Sodium Chloride Injection

    Spectra Medical Devices

    Why: Manufacturing firm, Huons, was cited for issues regarding product quality and sterility assurance. If the product sterility is compromised, patients may be exposed to microorganisms, endotoxins, or foreign matter. This...

    Class I: could cause serious harm or death

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Boston Scientific Enhance Transcarotid/Peripheral Access Kit Ref: SR-4f21g7d-Mp

    Galt Medical, sold nationwide

    Why: Black depth markings may detach from the outer sheath of the coaxial dilator introducer component of transcarotid-peripheral access kits.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Obp Medical

    Obp Medical, sold nationwide

    Why: There is a potential for vaginal speculums to contain a burr on the proximal plastic blade, which may introduce a sharp edge in the contact regions for both the patient and the healthcare provider.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Drug recall, ongoing

    Clear Eyes Maximum Itchy Eye Relief

    Prestige Brands Holdings, sold nationwide

    Why: Lack of assurance of sterility. The recall is due to potential contamination

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Gore Viabil Short Wire Biliary Endoprosthesis (2 items)

    W L Gore & Associates, sold nationwide

    Why: 10 mm diameter x 7 cm with transmural drainage holes (VSWVH1006) incorrectly labeled as 10 mm diameter x 10 cm length devices without transmural drainage holes (VSWVN1010).

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Bobby Balloon Guide Catheter Ref: Bob-895-Cn Bob-895-Emea Bob-895-Emea-Al B

    Microvention, sold nationwide

    Why: Due to an increase rate of balloon pinhole defects.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Allura Xper Fd. Model Numbers:

    Philips Medical Systems Nederland B.V., sold nationwide

    Why: Firmware issue potentially leading to loss of geometry movements.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Glidesheath Slender A-Kit

    Terumo Medical, sold nationwide

    Why: Product was packaged with the 0.025 guidewire instead of the 0.021 guidewire.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Navify Digital Pathology

    Ventana Medical Systems, sold nationwide

    Why: Due to complaints received for the Image Management System regarding image/metadata discrepancy with the Viewer window

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Thermo Fisher Diagnostics Neisseria Meningitidis Gp C

    Remel Europe, sold nationwide

    Why: Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Erbecryo

    Erbe USA, sold nationwide

    Why: A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the return path, leading to excessive...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Straumann Bone Level Tapered

    Straumann USA, sold nationwide

    Why: Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim may inadvertently contain implants that are 12mm in length instead of 14mm as the labeling would suggest.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Xhibit Central Station

    Spacelabs Healthcare, sold nationwide

    Why: Due to off-the-shelf display port component that has audio/video failures

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    60 in Non-Dehp Minibore Extension Set Res Me2010 Udi-Di Code:

    Bd Switzerland Sarl

    Why: Products may not have received adequate sterilization processing.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Gm Helix Implant

    Straumann USA, sold nationwide

    Why: There may be a mismatch between the implant contained inside the packaging and the information described on the outer carton label. If the the incorrect implant is installed, the issue could cause bone compression or...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Biofire Respiratory Panel

    Biofire Diagnostics, sold nationwide

    Why: Due to increase in false negative results

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Philips Azurion Rystem

    Philips Medical Systems Nederland B.V.

    Why: Two software related issues affecting Azurion R2.2.10 Systems: 1) Potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment and 2) Potential loss of...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Philips Azurion

    Philips Medical Systems Nederland B.V.

    Why: Two software related issues: 1) Potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment and 2) Potential loss of geometry movements that may lead to...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Endo-Model

    Waldemar Link Gmbh & Co. Kg (Mfg Site)

    Why: The affected Endo-Model replacement set for a Rotating Hinge tibial plateau incorrectly contains a Pure Hinge plateau. The incorrect plateau could lead to a prolonged or modified surgery as the plateau cannot be...

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)
  • Aug. 19, 2026

    Device recall, ongoing

    Pronephro Aki

    Bioporto Diagnostics A/S

    Why: The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users.

    Class II: could cause temporary or reversible harm

    The FDA record, with lot numbers (opens in a new tab)

Current drug shortages

68 drugs

DrugStatusUpdatedReasonCategory
Amino Acid Injection Current Nov. 10, 2026 Shortage of an active ingredient Gastroenterology
Dextrose Monohydrate 5% Injection Current Nov. 10, 2026 Demand increase for the drug Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Dextrose Monohydrate 70% Injection Current Nov. 10, 2026 Not stated Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Lidocaine Hydrochloride Injection Current Nov. 10, 2026 Other Cardiovascular
Sterile Water Irrigant Current Nov. 10, 2026 Discontinuation of the manufacture of the drug Gastroenterology, Other, Pediatric
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Current Nov. 9, 2026 Other Psychiatry
Atropine Sulfate Injection Current Nov. 9, 2026 Other Anesthesia, Neurology, Pediatric
Bupivacaine Hydrochloride Injection Current Nov. 9, 2026 Other Anesthesia
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Current Nov. 9, 2026 Other Anesthesia
Carboplatin Injection Current Nov. 9, 2026 Other Oncology
Clindamycin Phosphate Injection Current Nov. 9, 2026 Discontinuation of the manufacture of the drug Anti-Infective
Dobutamine Hydrochloride Injection Current Nov. 9, 2026 Other Cardiovascular, Pediatric, Renal
Dopamine Hydrochloride Injection Current Nov. 9, 2026 Other Cardiovascular
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Current Nov. 9, 2026 Other Anesthesia, Pediatric
Fentanyl Citrate Injection Current Nov. 9, 2026 Demand increase for the drug Analgesia/Addiction, Pediatric
Furosemide Injection Current Nov. 9, 2026 Other Cardiovascular
Heparin Sodium Injection Current Nov. 9, 2026 Other Hematology
Hydromorphone Hydrochloride Injection Current Nov. 9, 2026 Other Analgesia/Addiction
Ketorolac Tromethamine Injection Current Nov. 9, 2026 Other Analgesia/Addiction
Lorazepam Injection Current Nov. 9, 2026 Demand increase for the drug Neurology
Meperidine Hydrochloride Injection Current Nov. 9, 2026 Not stated Analgesia/Addiction
Methotrexate Sodium Injection Current Nov. 9, 2026 Other Rheumatology, Oncology
Midazolam Hydrochloride Injection Current Nov. 9, 2026 Other Anesthesia, Neurology
Morphine Sulfate Injection Current Nov. 9, 2026 Other Analgesia/Addiction
Rocuronium Bromide Injection Current Nov. 9, 2026 Delay in shipping of the drug Anesthesia
Sodium Acetate Injection Current Nov. 9, 2026 Other Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition
Sodium Bicarbonate Injection Current Nov. 9, 2026 Other Endocrinology/Metabolism, Gastroenterology, Pediatric
Sterile Water Injection Current Nov. 9, 2026 Demand increase for the drug Other
Sufentanil Citrate Injection Current Nov. 9, 2026 Other Analgesia/Addiction, Pediatric
Dexmedetomidine Hydrochloride Injection Current Nov. 6, 2026 Other Anesthesia
Dextrose Monohydrate 50% Injection Current Nov. 6, 2026 Demand increase for the drug Endocrinology/Metabolism, Gastroenterology, Pediatric
Methylprednisolone Acetate Injection Current Nov. 6, 2026 Demand increase for the drug Rheumatology
Penicillin G Benzathine Injection Current Nov. 6, 2026 Other Anti-Infective
Rifampin Injection Current Nov. 6, 2026 Discontinuation of the manufacture of the drug Anti-Infective
Quinapril Hydrochloride Tablet Current Nov. 4, 2026 Discontinuation of the manufacture of the drug Cardiovascular
Quinapril/Hydrochlorothiazide Tablet Current Nov. 4, 2026 Discontinuation of the manufacture of the drug Cardiovascular
Azacitidine Injection Current Nov. 3, 2026 Discontinuation of the manufacture of the drug Oncology
Cromolyn Sodium Concentrate Current Nov. 3, 2026 Other Pulmonary/Allergy
Dexamethasone Sodium Phosphate Injection Current Nov. 3, 2026 Demand increase for the drug Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology
Dextrose Monohydrate 10% Injection Current Nov. 3, 2026 Demand increase for the drug Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
Etomidate Injection Current Nov. 3, 2026 Other Anesthesia
Ifosfamide Injection Current Nov. 3, 2026 Demand increase for the drug Oncology, Pediatric
Lisdexamfetamine Dimesylate Capsule Current Nov. 3, 2026 Shortage of an active ingredient Psychiatry
Methylphenidate Hydrochloride Tablet, Extended Release Current Nov. 3, 2026 Discontinuation of the manufacture of the drug Psychiatry
Metronidazole Injection Current Nov. 3, 2026 Other Anti-Infective
Propranolol Hydrochloride Injection Current Nov. 3, 2026 Delay in shipping of the drug Cardiovascular
Remifentanil Hydrochloride Injection Current Nov. 3, 2026 Delay in shipping of the drug Analgesia/Addiction
Rifampin Capsule Current Nov. 3, 2026 Discontinuation of the manufacture of the drug Anti-Infective
Ropivacaine Hydrochloride Injection Current Nov. 3, 2026 Delay in shipping of the drug Anesthesia
Valproate Sodium Injection Current Nov. 3, 2026 Demand increase for the drug Neurology
Echothiophate Iodide Ophthalmic Solution Current Nov. 2, 2026 Not stated Ophthalmology
Hydroxocobalamin Injection Current Nov. 2, 2026 Other Other
Lisdexamfetamine Dimesylate Tablet, Chewable Current Nov. 2, 2026 Not stated Psychiatry
Streptozocin Powder, For Solution Current Nov. 2, 2026 Other Oncology
Technetium TC-99M Pyrophosphate Kit Injection Current Nov. 2, 2026 Shortage of an active ingredient Medical Imaging
Furosemide Oral Solution Current Oct. 27, 2026 Not stated Cardiovascular
Bacitracin Ophthalmic Ointment Current Oct. 23, 2026 Discontinuation of the manufacture of the drug Anti-Infective, Ophthalmology
Pentostatin Injection Current Oct. 21, 2026 Other Oncology
Methylphenidate Film, Extended Release Current Oct. 16, 2026 Not stated Psychiatry
Conivaptan Hydrochloride Injection Current Oct. 15, 2026 Delay in shipping of the drug Cardiovascular
Desmopressin Acetate Spray Current Oct. 15, 2026 Delay in shipping of the drug Hematology
Riluzole Oral Suspension Current Oct. 15, 2026 Requirements related to complying with good manufacturing practices Neurology
Cefotaxime Sodium Powder, for Solution Current Oct. 14, 2026 Demand increase for the drug Anti-Infective, Pediatric
Liraglutide Injection Current Oct. 14, 2026 Discontinuation of the manufacture of the drug Endocrinology/Metabolism
Promethazine Hydrochloride Injection Current Oct. 14, 2026 Demand increase for the drug Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy
Flurazepam Hydrochloride Capsule Current Sept. 15, 2026 Regulatory delay Neurology, Other
Triamcinolone Hexacetonide Injection Current Sept. 15, 2026 Not stated Rheumatology
Isocarboxazid Tablet Current Aug. 6, 2026 Other Psychiatry

Sources: openFDA recall and shortage records (opens in a new tab)

This Week in Medicine

Know which recalls matter

Every Sunday: the recalls that touch common medicines, explained in plain English, plus the week’s top news.

Free. No spam. Unsubscribe anytime.